This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-21-5p | AKT2 | 1.75 | 0 | -0.01 | 0.9227 | miRNAWalker2 validate | -0.15 | 0.00352 | NA | |
2 | hsa-miR-29b-3p | AKT2 | -0.23 | 0.36746 | -0.01 | 0.9227 | MirTarget | -0.14 | 0.00022 | 26512921; 26564501; 24076586 | MicroRNA 29B mir 29b regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3;The expression of miR-29b was significantly upregualted by cisplatin treatmentwhile its target gene AKT2 was downregulated;Furthermore a feed-back loop comprising of c-Myc miR-29 family and Akt2 were found in myeloid leukemogenesis |
3 | hsa-miR-106b-5p | AKT3 | 1.71 | 0 | -0.75 | 0.06936 | miRNATAP | -0.37 | 7.0E-5 | NA | |
4 | hsa-miR-107 | AKT3 | 0.9 | 5.0E-5 | -0.75 | 0.06936 | PITA; miRanda | -0.6 | 0 | NA | |
5 | hsa-miR-15b-5p | AKT3 | 1.62 | 0 | -0.75 | 0.06936 | miRNATAP | -0.36 | 0.00041 | NA | |
6 | hsa-miR-16-5p | AKT3 | 1.01 | 1.0E-5 | -0.75 | 0.06936 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.47 | 0.00031 | NA | |
7 | hsa-miR-17-3p | AKT3 | 1.31 | 0 | -0.75 | 0.06936 | miRNATAP | -0.52 | 0 | NA | |
8 | hsa-miR-17-5p | AKT3 | 1.66 | 0 | -0.75 | 0.06936 | TargetScan; miRNATAP | -0.28 | 0.0027 | NA | |
9 | hsa-miR-29a-3p | AKT3 | -0.11 | 0.61501 | -0.75 | 0.06936 | miRNATAP | -0.41 | 0.00212 | NA | |
10 | hsa-miR-29b-3p | AKT3 | -0.23 | 0.36746 | -0.75 | 0.06936 | miRNATAP | -0.34 | 0.00361 | 26512921 | MicroRNA 29B mir 29b regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3 |
11 | hsa-miR-32-3p | AKT3 | 0.58 | 0.11837 | -0.75 | 0.06936 | mirMAP | -0.32 | 0.00023 | NA | |
12 | hsa-miR-320b | AKT3 | 1.11 | 0.0005 | -0.75 | 0.06936 | PITA; miRanda; miRNATAP | -0.26 | 0.0039 | NA | |
13 | hsa-miR-335-3p | AKT3 | 2.52 | 0 | -0.75 | 0.06936 | mirMAP | -0.22 | 0.00074 | NA | |
14 | hsa-miR-33a-3p | AKT3 | 0.35 | 0.32171 | -0.75 | 0.06936 | mirMAP | -0.38 | 2.0E-5 | NA | |
15 | hsa-miR-362-3p | AKT3 | -0.03 | 0.91378 | -0.75 | 0.06936 | miRanda | -0.38 | 4.0E-5 | NA | |
16 | hsa-miR-362-5p | AKT3 | -0.35 | 0.35491 | -0.75 | 0.06936 | PITA; TargetScan; miRNATAP | -0.23 | 0.00253 | NA | |
17 | hsa-miR-501-3p | AKT3 | 0.73 | 0.02704 | -0.75 | 0.06936 | miRNATAP | -0.39 | 1.0E-5 | NA | |
18 | hsa-miR-502-3p | AKT3 | -0.16 | 0.55747 | -0.75 | 0.06936 | miRNATAP | -0.5 | 0 | NA | |
19 | hsa-miR-505-3p | AKT3 | 0.83 | 0.00112 | -0.75 | 0.06936 | mirMAP | -0.35 | 0.00235 | 22051041 | We also find that Akt3 correlate inversely with miR-505 modulates drug sensitivity in MCF7-ADR |
20 | hsa-miR-548v | AKT3 | -0.16 | 0.70867 | -0.75 | 0.06936 | miRNATAP | -0.27 | 0.00031 | NA | |
21 | hsa-miR-577 | AKT3 | 0.91 | 0.22561 | -0.75 | 0.06936 | mirMAP | -0.23 | 0 | NA | |
22 | hsa-miR-616-5p | AKT3 | 0.83 | 0.03478 | -0.75 | 0.06936 | mirMAP | -0.27 | 0.00041 | NA | |
23 | hsa-miR-125b-5p | ARRB1 | -0.51 | 0.13327 | -1.74 | 0.0001 | MirTarget | -0.27 | 0.00426 | NA | |
24 | hsa-miR-149-5p | ARRB1 | 0.71 | 0.29685 | -1.74 | 0.0001 | MirTarget | -0.46 | 0 | NA | |
25 | hsa-miR-185-3p | ARRB1 | 1.34 | 3.0E-5 | -1.74 | 0.0001 | MirTarget | -0.3 | 0.00212 | NA | |
26 | hsa-miR-22-3p | ARRB1 | 0.03 | 0.84509 | -1.74 | 0.0001 | MirTarget | -1.09 | 0 | NA | |
27 | hsa-miR-296-5p | ARRB1 | 0.93 | 0.06024 | -1.74 | 0.0001 | MirTarget; miRNATAP | -0.42 | 0 | NA | |
28 | hsa-miR-324-3p | ARRB1 | 1.05 | 0.00039 | -1.74 | 0.0001 | MirTarget | -0.51 | 0 | NA | |
29 | hsa-miR-331-3p | ARRB1 | 1.05 | 0.0001 | -1.74 | 0.0001 | MirTarget; miRNATAP | -0.55 | 0 | NA | |
30 | hsa-miR-455-3p | ARRB1 | 2.3 | 0 | -1.74 | 0.0001 | MirTarget | -0.46 | 0 | NA | |
31 | hsa-miR-671-5p | ARRB1 | 0.95 | 0.00247 | -1.74 | 0.0001 | MirTarget | -0.37 | 0.00029 | NA | |
32 | hsa-miR-149-5p | ARRB2 | 0.71 | 0.29685 | 0.08 | 0.6689 | miRNAWalker2 validate | -0.14 | 0 | NA | |
33 | hsa-miR-199a-5p | ARRB2 | 0.37 | 0.23266 | 0.08 | 0.6689 | MirTarget; miRanda | -0.16 | 0.00021 | NA | |
34 | hsa-miR-199b-5p | ARRB2 | 0.12 | 0.67816 | 0.08 | 0.6689 | MirTarget; miRanda; miRNATAP | -0.16 | 0.00037 | NA | |
35 | hsa-miR-365a-3p | ARRB2 | -0.89 | 0.00255 | 0.08 | 0.6689 | MirTarget; miRNATAP | -0.25 | 0 | NA | |
36 | hsa-miR-10b-5p | ATF2 | -0.3 | 0.31239 | -0.02 | 0.89844 | MirTarget; miRNATAP | -0.13 | 0.00068 | NA | |
37 | hsa-miR-126-5p | ATF2 | 0.42 | 0.07532 | -0.02 | 0.89844 | mirMAP | -0.15 | 0.00299 | NA | |
38 | hsa-miR-212-3p | ATF2 | 0.96 | 0.00133 | -0.02 | 0.89844 | miRNATAP | -0.14 | 0.00026 | NA | |
39 | hsa-miR-590-3p | ATF2 | 1.12 | 0.00016 | -0.02 | 0.89844 | MirTarget; miRanda; mirMAP; miRNATAP | -0.12 | 0.00263 | NA | |
40 | hsa-miR-192-3p | BDNF | 0.36 | 0.74117 | 0.74 | 0.18381 | MirTarget; miRNATAP | -0.11 | 0.00424 | NA | |
41 | hsa-miR-29b-2-5p | BDNF | -1.7 | 0 | 0.74 | 0.18381 | mirMAP | -0.38 | 0.00762 | NA | |
42 | hsa-miR-338-5p | BDNF | -1.2 | 0.01003 | 0.74 | 0.18381 | miRNATAP | -0.3 | 0.00033 | NA | |
43 | hsa-miR-27b-3p | CACNA1A | 0.08 | 0.72527 | -0.24 | 0.66624 | MirTarget | -0.47 | 0.00464 | NA | |
44 | hsa-miR-107 | CACNA1B | 0.9 | 5.0E-5 | 0.22 | 0.84313 | miRanda | -1.33 | 0.00013 | NA | |
45 | hsa-miR-140-3p | CACNA1B | -0.3 | 0.12754 | 0.22 | 0.84313 | MirTarget; miRNATAP | -2.3 | 0 | NA | |
46 | hsa-miR-200a-3p | CACNA1B | 0.72 | 0.19391 | 0.22 | 0.84313 | mirMAP | -0.48 | 0.0006 | NA | |
47 | hsa-miR-335-5p | CACNA1B | 1.6 | 6.0E-5 | 0.22 | 0.84313 | miRNAWalker2 validate | -0.71 | 0.00018 | NA | |
48 | hsa-miR-3614-5p | CACNA1B | 1.1 | 0.00706 | 0.22 | 0.84313 | mirMAP; miRNATAP | -1.16 | 0 | NA | |
49 | hsa-miR-362-3p | CACNA1B | -0.03 | 0.91378 | 0.22 | 0.84313 | MirTarget; miRNATAP | -0.87 | 0.00033 | NA | |
50 | hsa-miR-429 | CACNA1B | 1.4 | 0.009 | 0.22 | 0.84313 | miRNATAP | -0.46 | 0.00145 | NA | |
51 | hsa-miR-7-1-3p | CACNA1B | 0.71 | 0.04123 | 0.22 | 0.84313 | MirTarget | -1.03 | 0 | NA | |
52 | hsa-let-7a-3p | CACNA1C | 0.5 | 0.04111 | -1.47 | 0.0005 | MirTarget | -0.59 | 0 | NA | |
53 | hsa-let-7b-3p | CACNA1C | 0.22 | 0.29604 | -1.47 | 0.0005 | MirTarget | -0.51 | 0.00059 | NA | |
54 | hsa-let-7f-1-3p | CACNA1C | 1.29 | 0 | -1.47 | 0.0005 | MirTarget | -0.44 | 7.0E-5 | NA | |
55 | hsa-miR-107 | CACNA1C | 0.9 | 5.0E-5 | -1.47 | 0.0005 | miRNATAP | -0.52 | 0.00014 | NA | |
56 | hsa-miR-1254 | CACNA1C | 0.94 | 0.06055 | -1.47 | 0.0005 | PITA; miRNATAP | -0.41 | 0 | NA | |
57 | hsa-miR-1271-5p | CACNA1C | 1.16 | 0.00208 | -1.47 | 0.0005 | MirTarget | -0.27 | 0.00098 | NA | |
58 | hsa-miR-148b-5p | CACNA1C | 1.04 | 0.00196 | -1.47 | 0.0005 | mirMAP | -0.34 | 0.00011 | NA | |
59 | hsa-miR-149-5p | CACNA1C | 0.71 | 0.29685 | -1.47 | 0.0005 | MirTarget | -0.17 | 8.0E-5 | NA | |
60 | hsa-miR-186-5p | CACNA1C | 0.15 | 0.43471 | -1.47 | 0.0005 | mirMAP | -0.63 | 9.0E-5 | NA | |
61 | hsa-miR-1976 | CACNA1C | 0.92 | 0.00012 | -1.47 | 0.0005 | MirTarget | -0.56 | 1.0E-5 | NA | |
62 | hsa-miR-19a-3p | CACNA1C | 1.27 | 0.00011 | -1.47 | 0.0005 | MirTarget | -0.5 | 0 | NA | |
63 | hsa-miR-19b-1-5p | CACNA1C | 1.39 | 0 | -1.47 | 0.0005 | MirTarget | -0.55 | 0 | NA | |
64 | hsa-miR-19b-3p | CACNA1C | 0.76 | 0.00653 | -1.47 | 0.0005 | MirTarget | -0.59 | 0 | NA | |
65 | hsa-miR-200b-3p | CACNA1C | 0.97 | 0.0595 | -1.47 | 0.0005 | MirTarget; TargetScan | -0.22 | 0.00019 | NA | |
66 | hsa-miR-200c-3p | CACNA1C | 1.28 | 0.0037 | -1.47 | 0.0005 | MirTarget | -0.41 | 0 | NA | |
67 | hsa-miR-26b-5p | CACNA1C | -0.3 | 0.16008 | -1.47 | 0.0005 | MirTarget; miRNATAP | -0.5 | 0.00056 | NA | |
68 | hsa-miR-320a | CACNA1C | 0.59 | 0.0119 | -1.47 | 0.0005 | miRNATAP | -0.4 | 0.00196 | NA | |
69 | hsa-miR-320b | CACNA1C | 1.11 | 0.0005 | -1.47 | 0.0005 | miRNATAP | -0.41 | 1.0E-5 | NA | |
70 | hsa-miR-330-5p | CACNA1C | 0.49 | 0.05122 | -1.47 | 0.0005 | miRanda | -0.54 | 1.0E-5 | NA | |
71 | hsa-miR-33a-5p | CACNA1C | 0.41 | 0.32143 | -1.47 | 0.0005 | MirTarget | -0.51 | 0 | NA | |
72 | hsa-miR-33b-5p | CACNA1C | 0.27 | 0.61481 | -1.47 | 0.0005 | MirTarget | -0.38 | 0 | NA | |
73 | hsa-miR-378a-5p | CACNA1C | -0.56 | 0.03446 | -1.47 | 0.0005 | MirTarget | -0.53 | 0 | NA | |
74 | hsa-miR-3922-3p | CACNA1C | 1.33 | 0.00067 | -1.47 | 0.0005 | mirMAP; miRNATAP | -0.33 | 0.00023 | NA | |
75 | hsa-miR-421 | CACNA1C | 1.81 | 0 | -1.47 | 0.0005 | MirTarget; PITA; miRanda; miRNATAP | -0.32 | 0.00018 | NA | |
76 | hsa-miR-429 | CACNA1C | 1.4 | 0.009 | -1.47 | 0.0005 | MirTarget; PITA; miRanda; miRNATAP | -0.25 | 1.0E-5 | NA | |
77 | hsa-miR-484 | CACNA1C | 0.71 | 0.00234 | -1.47 | 0.0005 | PITA; miRNATAP | -0.74 | 0 | NA | |
78 | hsa-miR-542-3p | CACNA1C | 0.76 | 0.00211 | -1.47 | 0.0005 | miRanda | -0.33 | 0.00762 | NA | |
79 | hsa-miR-577 | CACNA1C | 0.91 | 0.22561 | -1.47 | 0.0005 | PITA | -0.15 | 0.00039 | NA | |
80 | hsa-miR-582-5p | CACNA1C | -0.45 | 0.13462 | -1.47 | 0.0005 | PITA | -0.35 | 0.00052 | NA | |
81 | hsa-miR-589-3p | CACNA1C | 1.02 | 0.00578 | -1.47 | 0.0005 | MirTarget; mirMAP | -0.27 | 0.00102 | NA | |
82 | hsa-miR-671-3p | CACNA1C | 1.16 | 0.0004 | -1.47 | 0.0005 | miRNATAP | -0.52 | 0 | NA | |
83 | hsa-miR-7-1-3p | CACNA1C | 0.71 | 0.04123 | -1.47 | 0.0005 | MirTarget | -0.29 | 0.00107 | NA | |
84 | hsa-miR-877-5p | CACNA1C | 2.18 | 0 | -1.47 | 0.0005 | MirTarget | -0.38 | 0 | NA | |
85 | hsa-miR-93-3p | CACNA1C | 1.89 | 0 | -1.47 | 0.0005 | mirMAP | -0.59 | 0 | NA | |
86 | hsa-miR-944 | CACNA1C | 3.33 | 0.01778 | -1.47 | 0.0005 | mirMAP | -0.11 | 1.0E-5 | NA | |
87 | hsa-miR-96-5p | CACNA1C | 1.14 | 0.00943 | -1.47 | 0.0005 | MirTarget; TargetScan | -0.47 | 0 | NA | |
88 | hsa-let-7a-2-3p | CACNA1D | 0.2 | 0.64356 | -0.15 | 0.86217 | MirTarget | -0.48 | 0.00099 | NA | |
89 | hsa-let-7b-5p | CACNA1D | 0.06 | 0.7814 | -0.15 | 0.86217 | miRNATAP | -1.4 | 0 | NA | |
90 | hsa-miR-134-5p | CACNA1D | 0.57 | 0.10962 | -0.15 | 0.86217 | MirTarget | -0.8 | 0 | NA | |
91 | hsa-miR-203a-3p | CACNA1E | 1.45 | 0.03941 | -0.45 | 0.53451 | MirTarget | -0.23 | 0.00165 | NA | |
92 | hsa-miR-205-5p | CACNA1E | 3.14 | 0.02932 | -0.45 | 0.53451 | mirMAP | -0.11 | 0.00145 | NA | |
93 | hsa-miR-151a-3p | CACNA1G | 1 | 1.0E-5 | -0.55 | 0.31183 | MirTarget | -0.49 | 0.00446 | NA | |
94 | hsa-miR-32-5p | CACNA1H | 0.42 | 0.10646 | -2.22 | 1.0E-5 | miRNATAP | -0.72 | 0 | NA | |
95 | hsa-miR-361-3p | CACNA1H | -0.13 | 0.56605 | -2.22 | 1.0E-5 | MirTarget; mirMAP | -0.44 | 0.0094 | NA | |
96 | hsa-miR-92a-3p | CACNA1H | 1.22 | 1.0E-5 | -2.22 | 1.0E-5 | miRNATAP | -0.98 | 0 | NA | |
97 | hsa-let-7f-1-3p | CACNA2D1 | 1.29 | 0 | -1.61 | 0.02537 | mirMAP | -0.72 | 0.00016 | NA | |
98 | hsa-miR-107 | CACNA2D1 | 0.9 | 5.0E-5 | -1.61 | 0.02537 | PITA; miRanda; miRNATAP | -1.07 | 0 | NA | |
99 | hsa-miR-141-3p | CACNA2D1 | 1.46 | 0.00116 | -1.61 | 0.02537 | TargetScan | -0.33 | 0.00413 | NA | |
100 | hsa-miR-16-2-3p | CACNA2D1 | 1.8 | 0 | -1.61 | 0.02537 | mirMAP | -0.49 | 0.00268 | NA | |
101 | hsa-miR-16-5p | CACNA2D1 | 1.01 | 1.0E-5 | -1.61 | 0.02537 | miRNAWalker2 validate | -1.06 | 0 | NA | |
102 | hsa-miR-181b-5p | CACNA2D1 | 1.64 | 0 | -1.61 | 0.02537 | mirMAP | -0.45 | 0.00934 | NA | |
103 | hsa-miR-200b-3p | CACNA2D1 | 0.97 | 0.0595 | -1.61 | 0.02537 | TargetScan | -0.32 | 0.00136 | NA | |
104 | hsa-miR-32-3p | CACNA2D1 | 0.58 | 0.11837 | -1.61 | 0.02537 | mirMAP | -0.44 | 0.00468 | NA | |
105 | hsa-miR-330-3p | CACNA2D1 | 0.8 | 0.00747 | -1.61 | 0.02537 | mirMAP | -0.7 | 4.0E-5 | NA | |
106 | hsa-miR-335-3p | CACNA2D1 | 2.52 | 0 | -1.61 | 0.02537 | mirMAP | -0.43 | 0.00023 | NA | |
107 | hsa-miR-33a-3p | CACNA2D1 | 0.35 | 0.32171 | -1.61 | 0.02537 | mirMAP | -0.45 | 0.00349 | NA | |
108 | hsa-miR-96-5p | CACNA2D1 | 1.14 | 0.00943 | -1.61 | 0.02537 | TargetScan; miRNATAP | -0.39 | 0.00147 | NA | |
109 | hsa-miR-182-5p | CACNA2D2 | 0.89 | 0.03106 | -3 | 0 | miRNATAP | -0.26 | 0.00833 | NA | |
110 | hsa-miR-205-5p | CACNA2D2 | 3.14 | 0.02932 | -3 | 0 | miRNATAP | -0.12 | 2.0E-5 | NA | |
111 | hsa-miR-22-5p | CACNA2D2 | 0.8 | 0.0008 | -3 | 0 | mirMAP | -0.54 | 0.00168 | NA | |
112 | hsa-miR-3614-5p | CACNA2D2 | 1.1 | 0.00706 | -3 | 0 | mirMAP | -0.33 | 0.00109 | NA | |
113 | hsa-miR-455-3p | CACNA2D2 | 2.3 | 0 | -3 | 0 | PITA; miRNATAP | -0.48 | 0 | NA | |
114 | hsa-miR-18a-3p | CACNA2D3 | 2.35 | 0 | -2.09 | 0.00344 | miRNAWalker2 validate | -0.52 | 1.0E-5 | NA | |
115 | hsa-miR-429 | CACNA2D3 | 1.4 | 0.009 | -2.09 | 0.00344 | miRanda | -0.25 | 0.00817 | NA | |
116 | hsa-miR-615-3p | CACNA2D3 | 2.83 | 3.0E-5 | -2.09 | 0.00344 | miRanda | -0.36 | 0.00037 | NA | |
117 | hsa-miR-299-5p | CACNB1 | -0.17 | 0.63894 | 0.77 | 0.00894 | miRNATAP | -0.16 | 0.00455 | NA | |
118 | hsa-let-7a-3p | CACNB2 | 0.5 | 0.04111 | -2.09 | 1.0E-5 | MirTarget; mirMAP | -0.65 | 0 | NA | |
119 | hsa-let-7b-3p | CACNB2 | 0.22 | 0.29604 | -2.09 | 1.0E-5 | MirTarget; mirMAP | -0.77 | 0 | NA | |
120 | hsa-let-7f-1-3p | CACNB2 | 1.29 | 0 | -2.09 | 1.0E-5 | MirTarget; mirMAP | -0.71 | 0 | NA | |
121 | hsa-miR-103a-2-5p | CACNB2 | 0.81 | 0.01999 | -2.09 | 1.0E-5 | MirTarget | -0.32 | 0.00095 | NA | |
122 | hsa-miR-144-5p | CACNB2 | -0.64 | 0.17347 | -2.09 | 1.0E-5 | mirMAP | -0.26 | 0.00021 | NA | |
123 | hsa-miR-16-5p | CACNB2 | 1.01 | 1.0E-5 | -2.09 | 1.0E-5 | miRNAWalker2 validate | -0.99 | 0 | NA | |
124 | hsa-miR-181a-5p | CACNB2 | 1.39 | 0 | -2.09 | 1.0E-5 | miRNATAP | -0.51 | 0.00031 | NA | |
125 | hsa-miR-181b-5p | CACNB2 | 1.64 | 0 | -2.09 | 1.0E-5 | miRNATAP | -0.45 | 6.0E-5 | NA | |
126 | hsa-miR-182-5p | CACNB2 | 0.89 | 0.03106 | -2.09 | 1.0E-5 | miRNATAP | -0.48 | 0 | NA | |
127 | hsa-miR-200c-5p | CACNB2 | 0.84 | 0.05746 | -2.09 | 1.0E-5 | MirTarget; miRNATAP | -0.24 | 0.00451 | NA | |
128 | hsa-miR-23a-3p | CACNB2 | 1.11 | 0 | -2.09 | 1.0E-5 | mirMAP | -0.91 | 0 | NA | |
129 | hsa-miR-27a-3p | CACNB2 | 1.3 | 0 | -2.09 | 1.0E-5 | MirTarget; miRNATAP | -0.87 | 0 | NA | |
130 | hsa-miR-29a-5p | CACNB2 | 0.59 | 0.02301 | -2.09 | 1.0E-5 | MirTarget | -0.38 | 0.00392 | NA | |
131 | hsa-miR-31-5p | CACNB2 | 0.67 | 0.3818 | -2.09 | 1.0E-5 | MirTarget; miRNATAP | -0.24 | 0 | NA | |
132 | hsa-miR-32-3p | CACNB2 | 0.58 | 0.11837 | -2.09 | 1.0E-5 | mirMAP; miRNATAP | -0.37 | 0.00029 | NA | |
133 | hsa-miR-339-5p | CACNB2 | 0.77 | 0.00817 | -2.09 | 1.0E-5 | miRNATAP | -0.51 | 1.0E-5 | NA | |
134 | hsa-miR-3653-3p | CACNB2 | 0.6 | 0.09439 | -2.09 | 1.0E-5 | MirTarget | -0.26 | 0.00537 | NA | |
135 | hsa-miR-369-3p | CACNB2 | 0.32 | 0.35899 | -2.09 | 1.0E-5 | PITA | -0.26 | 0.00792 | NA | |
136 | hsa-miR-370-3p | CACNB2 | 1.03 | 0.00666 | -2.09 | 1.0E-5 | MirTarget | -0.27 | 0.00202 | NA | |
137 | hsa-miR-429 | CACNB2 | 1.4 | 0.009 | -2.09 | 1.0E-5 | PITA; miRanda; miRNATAP | -0.28 | 0 | NA | |
138 | hsa-miR-550a-3p | CACNB2 | 2.06 | 0 | -2.09 | 1.0E-5 | MirTarget; miRNATAP | -0.45 | 0 | NA | |
139 | hsa-miR-590-3p | CACNB2 | 1.12 | 0.00016 | -2.09 | 1.0E-5 | mirMAP | -0.61 | 0 | NA | |
140 | hsa-miR-615-3p | CACNB2 | 2.83 | 3.0E-5 | -2.09 | 1.0E-5 | miRanda | -0.31 | 0 | NA | |
141 | hsa-miR-654-5p | CACNB2 | 0.97 | 0.00586 | -2.09 | 1.0E-5 | MirTarget | -0.27 | 0.00721 | NA | |
142 | hsa-miR-7-1-3p | CACNB2 | 0.71 | 0.04123 | -2.09 | 1.0E-5 | mirMAP | -0.27 | 0.00506 | NA | |
143 | hsa-miR-93-3p | CACNB2 | 1.89 | 0 | -2.09 | 1.0E-5 | MirTarget; miRNATAP | -0.51 | 0 | NA | |
144 | hsa-miR-96-5p | CACNB2 | 1.14 | 0.00943 | -2.09 | 1.0E-5 | miRNATAP | -0.5 | 0 | NA | |
145 | hsa-miR-140-3p | CACNB3 | -0.3 | 0.12754 | 0.57 | 0.0123 | PITA; miRNATAP | -0.25 | 0.00312 | NA | |
146 | hsa-miR-186-5p | CACNB3 | 0.15 | 0.43471 | 0.57 | 0.0123 | miRNATAP | -0.41 | 0 | NA | |
147 | hsa-miR-339-5p | CACNB3 | 0.77 | 0.00817 | 0.57 | 0.0123 | miRanda | -0.15 | 0.00771 | NA | |
148 | hsa-miR-361-3p | CACNB3 | -0.13 | 0.56605 | 0.57 | 0.0123 | mirMAP | -0.4 | 0 | NA | |
149 | hsa-let-7d-5p | CACNB4 | 0.98 | 0 | -2.12 | 0.00021 | miRNATAP | -0.61 | 0.00337 | NA | |
150 | hsa-miR-107 | CACNB4 | 0.9 | 5.0E-5 | -2.12 | 0.00021 | miRanda | -0.52 | 0.00544 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | INTRACELLULAR SIGNAL TRANSDUCTION | 111 | 1572 | 1.403e-82 | 6.528e-79 |
2 | SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION | 74 | 404 | 9.736e-82 | 2.265e-78 |
3 | PROTEIN PHOSPHORYLATION | 93 | 944 | 1.839e-79 | 2.852e-76 |
4 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 110 | 1977 | 2.142e-70 | 2.491e-67 |
5 | REGULATION OF MAPK CASCADE | 77 | 660 | 1.467e-69 | 1.365e-66 |
6 | PHOSPHORYLATION | 93 | 1228 | 8.052e-69 | 6.245e-66 |
7 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 101 | 1656 | 7.833e-67 | 5.207e-64 |
8 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 103 | 1929 | 9.221e-63 | 5.363e-60 |
9 | REGULATION OF PROTEIN MODIFICATION PROCESS | 98 | 1710 | 9.29e-62 | 4.803e-59 |
10 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 99 | 1791 | 4.637e-61 | 2.158e-58 |
11 | POSITIVE REGULATION OF MAPK CASCADE | 63 | 470 | 1.208e-59 | 5.111e-57 |
12 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 94 | 1618 | 3.814e-59 | 1.479e-56 |
13 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 76 | 876 | 1.081e-58 | 3.869e-56 |
14 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 80 | 1036 | 3.084e-58 | 9.567e-56 |
15 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 80 | 1036 | 3.084e-58 | 9.567e-56 |
16 | REGULATION OF MAP KINASE ACTIVITY | 55 | 319 | 6.908e-58 | 2.009e-55 |
17 | POSITIVE REGULATION OF KINASE ACTIVITY | 62 | 482 | 1.763e-57 | 4.826e-55 |
18 | REGULATION OF KINASE ACTIVITY | 72 | 776 | 2.653e-57 | 6.857e-55 |
19 | REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 60 | 470 | 2.751e-55 | 6.738e-53 |
20 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 79 | 1135 | 6.455e-54 | 1.502e-51 |
21 | POSITIVE REGULATION OF CELL COMMUNICATION | 86 | 1532 | 8.055e-52 | 1.785e-49 |
22 | REGULATION OF TRANSFERASE ACTIVITY | 72 | 946 | 3.436e-51 | 7.267e-49 |
23 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 85 | 1518 | 5.246e-51 | 1.061e-48 |
24 | POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 62 | 616 | 8.893e-51 | 1.724e-48 |
25 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 84 | 1492 | 1.78e-50 | 3.314e-48 |
26 | ACTIVATION OF PROTEIN KINASE ACTIVITY | 46 | 279 | 4.152e-47 | 7.431e-45 |
27 | POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 40 | 289 | 1.158e-37 | 1.995e-35 |
28 | REGULATION OF CELL DEATH | 68 | 1472 | 4.321e-34 | 7.18e-32 |
29 | POSITIVE REGULATION OF MAP KINASE ACTIVITY | 32 | 207 | 1.093e-31 | 1.753e-29 |
30 | RESPONSE TO GROWTH FACTOR | 41 | 475 | 3.327e-30 | 5.16e-28 |
31 | STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 25 | 103 | 4.052e-30 | 6.082e-28 |
32 | REGULATION OF RESPONSE TO STRESS | 61 | 1468 | 1.147e-27 | 1.667e-25 |
33 | ACTIVATION OF MAPKK ACTIVITY | 19 | 52 | 5.388e-27 | 7.597e-25 |
34 | JNK CASCADE | 21 | 82 | 5.663e-26 | 7.75e-24 |
35 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 43 | 689 | 6.162e-26 | 8.192e-24 |
36 | REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 27 | 197 | 2.407e-25 | 3.111e-23 |
37 | CELL DEATH | 49 | 1001 | 6.035e-25 | 7.589e-23 |
38 | IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 31 | 323 | 3.2e-24 | 3.919e-22 |
39 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 63 | 1848 | 5.994e-24 | 7.151e-22 |
40 | ACTIVATION OF MAPK ACTIVITY | 23 | 137 | 8.483e-24 | 9.868e-22 |
41 | REGULATION OF IMMUNE SYSTEM PROCESS | 55 | 1403 | 1.746e-23 | 1.982e-21 |
42 | FC EPSILON RECEPTOR SIGNALING PATHWAY | 23 | 142 | 2.011e-23 | 2.228e-21 |
43 | REGULATION OF IMMUNE RESPONSE | 44 | 858 | 4.176e-23 | 4.519e-21 |
44 | POSITIVE REGULATION OF CELL DEATH | 38 | 605 | 5.668e-23 | 5.994e-21 |
45 | REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 31 | 365 | 1.279e-22 | 1.323e-20 |
46 | NEGATIVE REGULATION OF CELL DEATH | 43 | 872 | 6.603e-22 | 6.679e-20 |
47 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 34 | 498 | 1.04e-21 | 1.03e-19 |
48 | PEPTIDYL AMINO ACID MODIFICATION | 42 | 841 | 1.358e-21 | 1.316e-19 |
49 | REGULATION OF CELL DIFFERENTIATION | 54 | 1492 | 2.084e-21 | 1.979e-19 |
50 | REGULATION OF TRANSPORT | 59 | 1804 | 2.313e-21 | 2.153e-19 |
51 | REGULATION OF JNK CASCADE | 22 | 159 | 6.91e-21 | 6.304e-19 |
52 | NEGATIVE REGULATION OF CELL COMMUNICATION | 48 | 1192 | 8.323e-21 | 7.448e-19 |
53 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 47 | 1142 | 9.668e-21 | 8.487e-19 |
54 | CELL DEVELOPMENT | 52 | 1426 | 1.052e-20 | 9.062e-19 |
55 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 56 | 1672 | 1.16e-20 | 9.811e-19 |
56 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 58 | 1805 | 1.365e-20 | 1.134e-18 |
57 | CELL CELL SIGNALING | 39 | 767 | 2.639e-20 | 2.154e-18 |
58 | PEPTIDYL SERINE MODIFICATION | 21 | 148 | 3.248e-20 | 2.606e-18 |
59 | POSITIVE REGULATION OF GENE EXPRESSION | 56 | 1733 | 6.245e-20 | 4.925e-18 |
60 | POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 20 | 135 | 1.103e-19 | 8.416e-18 |
61 | CELLULAR RESPONSE TO STRESS | 53 | 1565 | 1.1e-19 | 8.416e-18 |
62 | FC RECEPTOR SIGNALING PATHWAY | 23 | 206 | 1.239e-19 | 9.297e-18 |
63 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 43 | 1021 | 2.685e-19 | 1.983e-17 |
64 | RESPONSE TO ABIOTIC STIMULUS | 43 | 1024 | 2.998e-19 | 2.179e-17 |
65 | REGULATION OF NEURON DEATH | 24 | 252 | 8.145e-19 | 5.831e-17 |
66 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 48 | 1360 | 1.885e-18 | 1.329e-16 |
67 | REGULATION OF CELL PROLIFERATION | 49 | 1496 | 1.598e-17 | 1.11e-15 |
68 | RESPONSE TO EXTERNAL STIMULUS | 54 | 1821 | 1.669e-17 | 1.142e-15 |
69 | REGULATION OF HYDROLASE ACTIVITY | 46 | 1327 | 2.373e-17 | 1.6e-15 |
70 | RESPONSE TO ENDOGENOUS STIMULUS | 48 | 1450 | 2.476e-17 | 1.646e-15 |
71 | REGULATION OF CELLULAR RESPONSE TO STRESS | 34 | 691 | 2.796e-17 | 1.832e-15 |
72 | POSITIVE REGULATION OF CELL PROLIFERATION | 36 | 814 | 8.26e-17 | 5.338e-15 |
73 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 35 | 771 | 1.071e-16 | 6.829e-15 |
74 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 46 | 1381 | 1.096e-16 | 6.889e-15 |
75 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 36 | 823 | 1.167e-16 | 7.242e-15 |
76 | PROTEIN AUTOPHOSPHORYLATION | 20 | 192 | 1.341e-16 | 8.211e-15 |
77 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 46 | 1395 | 1.609e-16 | 9.723e-15 |
78 | VASCULATURE DEVELOPMENT | 28 | 469 | 1.911e-16 | 1.14e-14 |
79 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 35 | 788 | 2.091e-16 | 1.216e-14 |
80 | CIRCULATORY SYSTEM DEVELOPMENT | 35 | 788 | 2.091e-16 | 1.216e-14 |
81 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 39 | 1008 | 3.029e-16 | 1.74e-14 |
82 | POSITIVE REGULATION OF HYDROLASE ACTIVITY | 37 | 905 | 3.554e-16 | 2.017e-14 |
83 | POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 36 | 867 | 5.942e-16 | 3.331e-14 |
84 | REGULATION OF ERK1 AND ERK2 CASCADE | 21 | 238 | 6.684e-16 | 3.703e-14 |
85 | PEPTIDYL TYROSINE MODIFICATION | 19 | 186 | 1.16e-15 | 6.349e-14 |
86 | WOUND HEALING | 27 | 470 | 1.802e-15 | 9.751e-14 |
87 | REGULATION OF NEURON APOPTOTIC PROCESS | 19 | 192 | 2.097e-15 | 1.121e-13 |
88 | MEMBRANE DEPOLARIZATION | 13 | 61 | 2.368e-15 | 1.252e-13 |
89 | RESPONSE TO WOUNDING | 29 | 563 | 2.518e-15 | 1.316e-13 |
90 | RAS PROTEIN SIGNAL TRANSDUCTION | 17 | 143 | 3.07e-15 | 1.587e-13 |
91 | NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 30 | 616 | 3.502e-15 | 1.791e-13 |
92 | NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 39 | 1087 | 3.643e-15 | 1.842e-13 |
93 | POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 20 | 228 | 3.832e-15 | 1.917e-13 |
94 | NEGATIVE REGULATION OF MAPK CASCADE | 17 | 145 | 3.888e-15 | 1.925e-13 |
95 | ORGAN MORPHOGENESIS | 34 | 841 | 9.598e-15 | 4.701e-13 |
96 | IMMUNE SYSTEM PROCESS | 52 | 1984 | 1.356e-14 | 6.571e-13 |
97 | POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 16 | 132 | 1.52e-14 | 7.29e-13 |
98 | SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 23 | 352 | 1.746e-14 | 8.291e-13 |
99 | TISSUE DEVELOPMENT | 45 | 1518 | 1.861e-14 | 8.747e-13 |
100 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 39 | 1152 | 2.395e-14 | 1.114e-12 |
101 | NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 25 | 437 | 2.422e-14 | 1.116e-12 |
102 | NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 27 | 541 | 5.491e-14 | 2.48e-12 |
103 | NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 27 | 541 | 5.491e-14 | 2.48e-12 |
104 | REGULATION OF ION TRANSPORT | 28 | 592 | 6.708e-14 | 3.001e-12 |
105 | TUBE DEVELOPMENT | 27 | 552 | 8.89e-14 | 3.939e-12 |
106 | NEGATIVE REGULATION OF PHOSPHORYLATION | 24 | 422 | 9.523e-14 | 4.18e-12 |
107 | REGULATION OF TRANSMEMBRANE TRANSPORT | 24 | 426 | 1.169e-13 | 5.085e-12 |
108 | NEUROGENESIS | 42 | 1402 | 1.234e-13 | 5.317e-12 |
109 | REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 16 | 153 | 1.591e-13 | 6.792e-12 |
110 | POSITIVE REGULATION OF TRANSPORT | 34 | 936 | 2.084e-13 | 8.816e-12 |
111 | CALCIUM ION TRANSMEMBRANE TRANSPORT | 16 | 159 | 2.913e-13 | 1.221e-11 |
112 | REGULATION OF APOPTOTIC SIGNALING PATHWAY | 22 | 363 | 3.108e-13 | 1.291e-11 |
113 | PROTEIN DEPHOSPHORYLATION | 17 | 190 | 3.557e-13 | 1.465e-11 |
114 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 34 | 957 | 3.906e-13 | 1.593e-11 |
115 | INACTIVATION OF MAPK ACTIVITY | 9 | 26 | 3.937e-13 | 1.593e-11 |
116 | CALCIUM ION TRANSPORT | 18 | 223 | 4.115e-13 | 1.651e-11 |
117 | REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 15 | 138 | 5.317e-13 | 2.114e-11 |
118 | REGULATION OF CELLULAR LOCALIZATION | 39 | 1277 | 6.289e-13 | 2.48e-11 |
119 | POSITIVE REGULATION OF LOCOMOTION | 23 | 420 | 7.154e-13 | 2.797e-11 |
120 | MODULATION OF SYNAPTIC TRANSMISSION | 20 | 301 | 7.362e-13 | 2.855e-11 |
121 | NEGATIVE REGULATION OF MAP KINASE ACTIVITY | 12 | 73 | 7.899e-13 | 3.038e-11 |
122 | HEART DEVELOPMENT | 24 | 466 | 8.099e-13 | 3.089e-11 |
123 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 34 | 983 | 8.304e-13 | 3.141e-11 |
124 | CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS | 12 | 74 | 9.362e-13 | 3.513e-11 |
125 | ACTIVATION OF IMMUNE RESPONSE | 23 | 427 | 1.007e-12 | 3.689e-11 |
126 | POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE | 16 | 172 | 9.932e-13 | 3.689e-11 |
127 | POSITIVE REGULATION OF IMMUNE RESPONSE | 26 | 563 | 1.001e-12 | 3.689e-11 |
128 | REGULATION OF GTPASE ACTIVITY | 28 | 673 | 1.517e-12 | 5.515e-11 |
129 | GLAND DEVELOPMENT | 22 | 395 | 1.684e-12 | 6.075e-11 |
130 | INOSITOL LIPID MEDIATED SIGNALING | 14 | 124 | 1.924e-12 | 6.887e-11 |
131 | MORPHOGENESIS OF AN EPITHELIUM | 22 | 400 | 2.161e-12 | 7.677e-11 |
132 | BLOOD VESSEL MORPHOGENESIS | 21 | 364 | 2.872e-12 | 1.012e-10 |
133 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 30 | 799 | 2.946e-12 | 1.031e-10 |
134 | NEURON PROJECTION DEVELOPMENT | 25 | 545 | 3.315e-12 | 1.151e-10 |
135 | CARDIAC CONDUCTION | 12 | 82 | 3.339e-12 | 1.151e-10 |
136 | RESPONSE TO RADIATION | 22 | 413 | 4.067e-12 | 1.391e-10 |
137 | INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 13 | 106 | 4.172e-12 | 1.417e-10 |
138 | FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 12 | 84 | 4.49e-12 | 1.514e-10 |
139 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 20 | 337 | 5.88e-12 | 1.968e-10 |
140 | REGULATION OF CYTOKINE PRODUCTION | 25 | 563 | 6.719e-12 | 2.233e-10 |
141 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 33 | 1004 | 7.572e-12 | 2.499e-10 |
142 | EPITHELIUM DEVELOPMENT | 32 | 945 | 7.645e-12 | 2.505e-10 |
143 | POSITIVE REGULATION OF CELL DEVELOPMENT | 23 | 472 | 7.828e-12 | 2.547e-10 |
144 | CELL ACTIVATION | 25 | 568 | 8.136e-12 | 2.629e-10 |
145 | REGULATION OF CELL DEVELOPMENT | 30 | 836 | 9.138e-12 | 2.932e-10 |
146 | DIVALENT INORGANIC CATION TRANSPORT | 18 | 268 | 9.256e-12 | 2.95e-10 |
147 | NEGATIVE REGULATION OF MOLECULAR FUNCTION | 34 | 1079 | 1.095e-11 | 3.467e-10 |
148 | PLATELET ACTIVATION | 14 | 142 | 1.248e-11 | 3.925e-10 |
149 | ACTIVATION OF INNATE IMMUNE RESPONSE | 16 | 204 | 1.364e-11 | 4.259e-10 |
150 | NEURON DEVELOPMENT | 27 | 687 | 1.476e-11 | 4.58e-10 |
151 | REGULATION OF INNATE IMMUNE RESPONSE | 20 | 357 | 1.673e-11 | 5.156e-10 |
152 | RESPONSE TO MOLECULE OF BACTERIAL ORIGIN | 19 | 321 | 2.155e-11 | 6.596e-10 |
153 | MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 9 | 39 | 2.437e-11 | 7.411e-10 |
154 | REGULATION OF DEFENSE RESPONSE | 28 | 759 | 2.61e-11 | 7.836e-10 |
155 | LOCOMOTION | 34 | 1114 | 2.608e-11 | 7.836e-10 |
156 | NEURON DIFFERENTIATION | 30 | 874 | 2.742e-11 | 8.178e-10 |
157 | MULTICELLULAR ORGANISMAL SIGNALING | 13 | 123 | 2.854e-11 | 8.458e-10 |
158 | NEGATIVE REGULATION OF KINASE ACTIVITY | 17 | 250 | 2.966e-11 | 8.734e-10 |
159 | HEAD DEVELOPMENT | 27 | 709 | 3.022e-11 | 8.845e-10 |
160 | APOPTOTIC SIGNALING PATHWAY | 18 | 289 | 3.241e-11 | 9.427e-10 |
161 | LIPID PHOSPHORYLATION | 12 | 99 | 3.303e-11 | 9.545e-10 |
162 | PEPTIDYL TYROSINE DEPHOSPHORYLATION | 12 | 100 | 3.727e-11 | 1.07e-09 |
163 | NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 13 | 126 | 3.884e-11 | 1.109e-09 |
164 | REGULATION OF PROTEIN LOCALIZATION | 31 | 950 | 4.355e-11 | 1.236e-09 |
165 | EMBRYO DEVELOPMENT | 30 | 894 | 4.773e-11 | 1.346e-09 |
166 | CELL PROJECTION ORGANIZATION | 30 | 902 | 5.931e-11 | 1.662e-09 |
167 | REGULATION OF JUN KINASE ACTIVITY | 11 | 81 | 6.346e-11 | 1.768e-09 |
168 | RESPONSE TO DRUG | 21 | 431 | 6.857e-11 | 1.899e-09 |
169 | POSITIVE REGULATION OF CELL DIVISION | 13 | 132 | 7.023e-11 | 1.934e-09 |
170 | POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 14 | 162 | 7.455e-11 | 2.041e-09 |
171 | REGULATION OF GROWTH | 25 | 633 | 8.242e-11 | 2.243e-09 |
172 | IMMUNE SYSTEM DEVELOPMENT | 24 | 582 | 8.502e-11 | 2.3e-09 |
173 | NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS | 13 | 135 | 9.337e-11 | 2.511e-09 |
174 | POSITIVE REGULATION OF JUN KINASE ACTIVITY | 10 | 63 | 9.739e-11 | 2.604e-09 |
175 | REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING | 16 | 233 | 1.006e-10 | 2.676e-09 |
176 | REGULATION OF EPITHELIAL CELL MIGRATION | 14 | 166 | 1.034e-10 | 2.735e-09 |
177 | EMBRYONIC MORPHOGENESIS | 23 | 539 | 1.115e-10 | 2.93e-09 |
178 | PEPTIDYL THREONINE MODIFICATION | 9 | 46 | 1.206e-10 | 3.135e-09 |
179 | REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 9 | 46 | 1.206e-10 | 3.135e-09 |
180 | RESPONSE TO CARBOHYDRATE | 14 | 168 | 1.214e-10 | 3.139e-09 |
181 | REGULATION OF SECRETION | 26 | 699 | 1.223e-10 | 3.143e-09 |
182 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 29 | 872 | 1.301e-10 | 3.326e-09 |
183 | POSITIVE REGULATION OF GROWTH | 16 | 238 | 1.38e-10 | 3.508e-09 |
184 | NEGATIVE REGULATION OF NEURON DEATH | 14 | 171 | 1.538e-10 | 3.89e-09 |
185 | RESPONSE TO LIGHT STIMULUS | 17 | 280 | 1.751e-10 | 4.404e-09 |
186 | REGULATION OF CELL MORPHOGENESIS | 23 | 552 | 1.782e-10 | 4.457e-09 |
187 | POSITIVE REGULATION OF NEURON DEATH | 10 | 67 | 1.837e-10 | 4.571e-09 |
188 | POSITIVE REGULATION OF DEFENSE RESPONSE | 19 | 364 | 1.853e-10 | 4.585e-09 |
189 | NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 28 | 829 | 1.995e-10 | 4.902e-09 |
190 | TUBE MORPHOGENESIS | 18 | 323 | 2.001e-10 | 4.902e-09 |
191 | RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 13 | 144 | 2.107e-10 | 5.132e-09 |
192 | REGULATION OF CALCIUM ION TRANSPORT | 15 | 209 | 2.141e-10 | 5.188e-09 |
193 | RESPONSE TO FIBROBLAST GROWTH FACTOR | 12 | 116 | 2.178e-10 | 5.252e-09 |
194 | PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 9 | 49 | 2.202e-10 | 5.281e-09 |
195 | POSITIVE REGULATION OF INNATE IMMUNE RESPONSE | 16 | 246 | 2.251e-10 | 5.372e-09 |
196 | RESPONSE TO MECHANICAL STIMULUS | 15 | 210 | 2.289e-10 | 5.434e-09 |
197 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 17 | 285 | 2.304e-10 | 5.441e-09 |
198 | DEPHOSPHORYLATION | 17 | 286 | 2.432e-10 | 5.716e-09 |
199 | POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING | 14 | 179 | 2.827e-10 | 6.61e-09 |
200 | REGULATION OF INTRACELLULAR TRANSPORT | 24 | 621 | 3.172e-10 | 7.379e-09 |
201 | ACTION POTENTIAL | 11 | 94 | 3.296e-10 | 7.629e-09 |
202 | ANGIOGENESIS | 17 | 293 | 3.533e-10 | 8.139e-09 |
203 | POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 12 | 121 | 3.578e-10 | 8.2e-09 |
204 | REGULATION OF PROTEIN IMPORT | 14 | 183 | 3.788e-10 | 8.641e-09 |
205 | REGULATION OF ORGAN GROWTH | 10 | 73 | 4.412e-10 | 1.001e-08 |
206 | SINGLE ORGANISM BEHAVIOR | 19 | 384 | 4.561e-10 | 1.03e-08 |
207 | POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 9 | 53 | 4.617e-10 | 1.038e-08 |
208 | REGULATION OF HEART CONTRACTION | 15 | 221 | 4.675e-10 | 1.046e-08 |
209 | POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 13 | 154 | 4.875e-10 | 1.085e-08 |
210 | REGULATION OF ORGANELLE ORGANIZATION | 33 | 1178 | 4.96e-10 | 1.099e-08 |
211 | REGULATION OF MEMBRANE POTENTIAL | 18 | 343 | 5.275e-10 | 1.163e-08 |
212 | TISSUE MORPHOGENESIS | 22 | 533 | 5.487e-10 | 1.204e-08 |
213 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 26 | 750 | 5.543e-10 | 1.211e-08 |
214 | EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 11 | 99 | 5.808e-10 | 1.263e-08 |
215 | PHOSPHATIDYLINOSITOL METABOLIC PROCESS | 14 | 193 | 7.636e-10 | 1.653e-08 |
216 | REGULATION OF CELLULAR COMPONENT BIOGENESIS | 26 | 767 | 8.913e-10 | 1.92e-08 |
217 | REGULATION OF CELL CYCLE | 29 | 949 | 9.289e-10 | 1.983e-08 |
218 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 34 | 1275 | 9.287e-10 | 1.983e-08 |
219 | REGULATION OF VASCULATURE DEVELOPMENT | 15 | 233 | 9.736e-10 | 2.069e-08 |
220 | REGULATION OF CELL DIVISION | 16 | 272 | 9.812e-10 | 2.075e-08 |
221 | RESPONSE TO CYTOKINE | 25 | 714 | 1.009e-09 | 2.124e-08 |
222 | NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY | 7 | 28 | 2.343e-09 | 4.91e-08 |
223 | SYNAPTIC SIGNALING | 19 | 424 | 2.362e-09 | 4.928e-08 |
224 | REGULATION OF PHOSPHOLIPASE ACTIVITY | 9 | 64 | 2.656e-09 | 5.517e-08 |
225 | REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 14 | 213 | 2.76e-09 | 5.708e-08 |
226 | REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 7 | 29 | 3.067e-09 | 6.314e-08 |
227 | REGULATION OF CYTOPLASMIC TRANSPORT | 20 | 481 | 3.138e-09 | 6.433e-08 |
228 | RESPONSE TO HEAT | 10 | 89 | 3.225e-09 | 6.581e-08 |
229 | REGULATION OF CHEMOTAXIS | 13 | 180 | 3.328e-09 | 6.761e-08 |
230 | POSITIVE REGULATION OF LIPASE ACTIVITY | 9 | 66 | 3.519e-09 | 7.12e-08 |
231 | RESPONSE TO TEMPERATURE STIMULUS | 12 | 148 | 3.681e-09 | 7.416e-08 |
232 | REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 14 | 218 | 3.724e-09 | 7.469e-08 |
233 | REGULATION OF PROTEIN SECRETION | 18 | 389 | 3.879e-09 | 7.746e-08 |
234 | REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 14 | 220 | 4.189e-09 | 8.33e-08 |
235 | RESPONSE TO LIPID | 27 | 888 | 4.258e-09 | 8.43e-08 |
236 | POSITIVE REGULATION OF CHEMOTAXIS | 11 | 120 | 4.609e-09 | 9.086e-08 |
237 | POSITIVE REGULATION OF DNA METABOLIC PROCESS | 13 | 185 | 4.642e-09 | 9.114e-08 |
238 | SENSORY ORGAN DEVELOPMENT | 20 | 493 | 4.769e-09 | 9.323e-08 |
239 | REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT | 8 | 48 | 5.159e-09 | 1.004e-07 |
240 | DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 22 | 602 | 5.188e-09 | 1.006e-07 |
241 | NEGATIVE REGULATION OF TRANSFERASE ACTIVITY | 17 | 351 | 5.471e-09 | 1.056e-07 |
242 | CELLULAR COMPONENT MORPHOGENESIS | 27 | 900 | 5.661e-09 | 1.088e-07 |
243 | TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 10 | 95 | 6.142e-09 | 1.176e-07 |
244 | ACTIN FILAMENT BASED PROCESS | 19 | 450 | 6.24e-09 | 1.19e-07 |
245 | EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 21 | 554 | 6.308e-09 | 1.198e-07 |
246 | SALIVARY GLAND DEVELOPMENT | 7 | 32 | 6.478e-09 | 1.225e-07 |
247 | HEMOSTASIS | 16 | 311 | 6.727e-09 | 1.267e-07 |
248 | FACE DEVELOPMENT | 8 | 50 | 7.238e-09 | 1.358e-07 |
249 | REGULATION OF SYSTEM PROCESS | 20 | 507 | 7.649e-09 | 1.429e-07 |
250 | CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 7 | 33 | 8.165e-09 | 1.52e-07 |
251 | NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 10 | 98 | 8.334e-09 | 1.545e-07 |
252 | ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 13 | 195 | 8.769e-09 | 1.619e-07 |
253 | POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 20 | 514 | 9.629e-09 | 1.771e-07 |
254 | POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 11 | 129 | 9.911e-09 | 1.816e-07 |
255 | BEHAVIOR | 20 | 516 | 1.028e-08 | 1.875e-07 |
256 | REGULATION OF TRANSPORTER ACTIVITY | 13 | 198 | 1.054e-08 | 1.915e-07 |
257 | REGULATION OF CELL ADHESION | 22 | 629 | 1.147e-08 | 2.076e-07 |
258 | REGULATION OF METAL ION TRANSPORT | 16 | 325 | 1.254e-08 | 2.261e-07 |
259 | POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 10 | 103 | 1.355e-08 | 2.434e-07 |
260 | POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 11 | 133 | 1.366e-08 | 2.443e-07 |
261 | REGULATION OF BINDING | 15 | 283 | 1.37e-08 | 2.443e-07 |
262 | MORPHOGENESIS OF A BRANCHING STRUCTURE | 12 | 167 | 1.446e-08 | 2.568e-07 |
263 | POSITIVE REGULATION OF PROTEIN IMPORT | 10 | 104 | 1.489e-08 | 2.634e-07 |
264 | RESPONSE TO INORGANIC SUBSTANCE | 19 | 479 | 1.706e-08 | 3.007e-07 |
265 | REGULATION OF DEVELOPMENTAL GROWTH | 15 | 289 | 1.813e-08 | 3.184e-07 |
266 | POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 12 | 171 | 1.885e-08 | 3.298e-07 |
267 | MUSCLE STRUCTURE DEVELOPMENT | 18 | 432 | 1.968e-08 | 3.429e-07 |
268 | STRIATED MUSCLE CELL DIFFERENTIATION | 12 | 173 | 2.147e-08 | 3.728e-07 |
269 | CELL MOTILITY | 25 | 835 | 2.32e-08 | 3.998e-07 |
270 | LOCALIZATION OF CELL | 25 | 835 | 2.32e-08 | 3.998e-07 |
271 | REGULATION OF SYNAPTIC PLASTICITY | 11 | 140 | 2.336e-08 | 4.012e-07 |
272 | REGULATION OF BLOOD CIRCULATION | 15 | 295 | 2.383e-08 | 4.077e-07 |
273 | NEUROTROPHIN SIGNALING PATHWAY | 6 | 23 | 2.587e-08 | 4.409e-07 |
274 | GLYCEROPHOSPHOLIPID METABOLIC PROCESS | 15 | 297 | 2.607e-08 | 4.427e-07 |
275 | RHYTHMIC PROCESS | 15 | 298 | 2.726e-08 | 4.612e-07 |
276 | REGULATION OF LIPASE ACTIVITY | 9 | 83 | 2.773e-08 | 4.675e-07 |
277 | POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 14 | 258 | 3.172e-08 | 5.328e-07 |
278 | REGULATION OF NEURON DIFFERENTIATION | 20 | 554 | 3.343e-08 | 5.595e-07 |
279 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 15 | 303 | 3.397e-08 | 5.665e-07 |
280 | CELL PROLIFERATION | 22 | 672 | 3.722e-08 | 6.185e-07 |
281 | REGULATION OF CELL PROJECTION ORGANIZATION | 20 | 558 | 3.762e-08 | 6.23e-07 |
282 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 38 | 1784 | 3.886e-08 | 6.412e-07 |
283 | RESPONSE TO NITROGEN COMPOUND | 25 | 859 | 4.027e-08 | 6.617e-07 |
284 | REGULATION OF PROTEIN TARGETING | 15 | 307 | 4.038e-08 | 6.617e-07 |
285 | HOMEOSTATIC PROCESS | 32 | 1337 | 4.155e-08 | 6.784e-07 |
286 | REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 26 | 926 | 4.275e-08 | 6.93e-07 |
287 | REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 10 | 116 | 4.275e-08 | 6.93e-07 |
288 | INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 5 | 13 | 4.388e-08 | 7.089e-07 |
289 | REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 6 | 25 | 4.477e-08 | 7.208e-07 |
290 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 24 | 801 | 4.51e-08 | 7.237e-07 |
291 | NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 9 | 88 | 4.654e-08 | 7.441e-07 |
292 | REGULATION OF HEART GROWTH | 7 | 42 | 4.845e-08 | 7.72e-07 |
293 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 19 | 513 | 5.061e-08 | 8.037e-07 |
294 | POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION | 16 | 360 | 5.215e-08 | 8.253e-07 |
295 | REGULATION OF VESICLE MEDIATED TRANSPORT | 18 | 462 | 5.457e-08 | 8.607e-07 |
296 | CALCIUM MEDIATED SIGNALING | 9 | 90 | 5.672e-08 | 8.917e-07 |
297 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 13 | 229 | 5.922e-08 | 9.278e-07 |
298 | MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 5 | 14 | 6.78e-08 | 1.055e-06 |
299 | POSITIVE REGULATION OF P38MAPK CASCADE | 5 | 14 | 6.78e-08 | 1.055e-06 |
300 | REPRODUCTION | 31 | 1297 | 7.258e-08 | 1.126e-06 |
301 | RESPONSE TO BIOTIC STIMULUS | 25 | 886 | 7.311e-08 | 1.13e-06 |
302 | CONNECTIVE TISSUE DEVELOPMENT | 12 | 194 | 7.638e-08 | 1.177e-06 |
303 | RESPONSE TO BACTERIUM | 19 | 528 | 7.948e-08 | 1.22e-06 |
304 | EXOCRINE SYSTEM DEVELOPMENT | 7 | 45 | 7.982e-08 | 1.222e-06 |
305 | NEGATIVE REGULATION OF CELL PROLIFERATION | 21 | 643 | 8.135e-08 | 1.241e-06 |
306 | EYE DEVELOPMENT | 15 | 326 | 8.867e-08 | 1.344e-06 |
307 | MUSCLE CELL DIFFERENTIATION | 13 | 237 | 8.848e-08 | 1.344e-06 |
308 | RESPIRATORY SYSTEM DEVELOPMENT | 12 | 197 | 9.037e-08 | 1.365e-06 |
309 | NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 12 | 200 | 1.066e-07 | 1.606e-06 |
310 | REGULATION OF CELL ACTIVATION | 18 | 484 | 1.096e-07 | 1.624e-06 |
311 | GLAND MORPHOGENESIS | 9 | 97 | 1.093e-07 | 1.624e-06 |
312 | THYMUS DEVELOPMENT | 7 | 47 | 1.091e-07 | 1.624e-06 |
313 | POSITIVE REGULATION OF LIPID METABOLIC PROCESS | 10 | 128 | 1.092e-07 | 1.624e-06 |
314 | POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS | 7 | 47 | 1.091e-07 | 1.624e-06 |
315 | I KAPPAB KINASE NF KAPPAB SIGNALING | 8 | 70 | 1.107e-07 | 1.63e-06 |
316 | REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 70 | 1.107e-07 | 1.63e-06 |
317 | REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 16 | 381 | 1.134e-07 | 1.665e-06 |
318 | POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT | 6 | 29 | 1.168e-07 | 1.71e-06 |
319 | SYSTEM PROCESS | 37 | 1785 | 1.23e-07 | 1.795e-06 |
320 | BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 10 | 131 | 1.36e-07 | 1.977e-06 |
321 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 25 | 917 | 1.408e-07 | 2.041e-06 |
322 | REGULATION OF CATION TRANSMEMBRANE TRANSPORT | 12 | 208 | 1.634e-07 | 2.362e-06 |
323 | COGNITION | 13 | 251 | 1.722e-07 | 2.48e-06 |
324 | LIPID MODIFICATION | 12 | 210 | 1.813e-07 | 2.604e-06 |
325 | CELLULAR GLUCOSE HOMEOSTASIS | 8 | 75 | 1.91e-07 | 2.734e-06 |
326 | REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 5 | 17 | 2.054e-07 | 2.932e-06 |
327 | REGULATION OF PEPTIDE TRANSPORT | 13 | 256 | 2.161e-07 | 3.075e-06 |
328 | POSITIVE REGULATION OF LIPID KINASE ACTIVITY | 6 | 32 | 2.184e-07 | 3.098e-06 |
329 | INFLAMMATORY RESPONSE | 17 | 454 | 2.293e-07 | 3.243e-06 |
330 | NEURON PROJECTION MORPHOGENESIS | 16 | 402 | 2.345e-07 | 3.307e-06 |
331 | CELLULAR CHEMICAL HOMEOSTASIS | 19 | 570 | 2.592e-07 | 3.643e-06 |
332 | EMBRYONIC ORGAN DEVELOPMENT | 16 | 406 | 2.679e-07 | 3.755e-06 |
333 | GLYCEROLIPID METABOLIC PROCESS | 15 | 356 | 2.76e-07 | 3.857e-06 |
334 | POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 19 | 573 | 2.808e-07 | 3.912e-06 |
335 | INOSITOL PHOSPHATE MEDIATED SIGNALING | 5 | 18 | 2.825e-07 | 3.924e-06 |
336 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 16 | 408 | 2.862e-07 | 3.963e-06 |
337 | ERBB SIGNALING PATHWAY | 8 | 79 | 2.872e-07 | 3.966e-06 |
338 | CELLULAR MACROMOLECULE LOCALIZATION | 29 | 1234 | 2.929e-07 | 4.032e-06 |
339 | PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 9 | 109 | 2.996e-07 | 4.112e-06 |
340 | TAXIS | 17 | 464 | 3.115e-07 | 4.262e-06 |
341 | CELLULAR RESPONSE TO MECHANICAL STIMULUS | 8 | 80 | 3.169e-07 | 4.324e-06 |
342 | CRANIAL SKELETAL SYSTEM DEVELOPMENT | 7 | 55 | 3.331e-07 | 4.532e-06 |
343 | PHOSPHOLIPID METABOLIC PROCESS | 15 | 364 | 3.664e-07 | 4.971e-06 |
344 | T CELL RECEPTOR SIGNALING PATHWAY | 10 | 146 | 3.752e-07 | 5.075e-06 |
345 | POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 5 | 19 | 3.809e-07 | 5.131e-06 |
346 | REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 11 | 184 | 3.816e-07 | 5.131e-06 |
347 | CARTILAGE DEVELOPMENT | 10 | 147 | 3.998e-07 | 5.361e-06 |
348 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 15 | 368 | 4.21e-07 | 5.629e-06 |
349 | REGULATION OF PROTEOLYSIS | 21 | 711 | 4.296e-07 | 5.728e-06 |
350 | REGULATION OF ENDOTHELIAL CELL MIGRATION | 9 | 114 | 4.398e-07 | 5.847e-06 |
351 | POSITIVE REGULATION OF INTRACELLULAR TRANSPORT | 15 | 370 | 4.509e-07 | 5.96e-06 |
352 | POSITIVE REGULATION OF CYTOKINE PRODUCTION | 15 | 370 | 4.509e-07 | 5.96e-06 |
353 | NEUROMUSCULAR JUNCTION DEVELOPMENT | 6 | 36 | 4.568e-07 | 6.021e-06 |
354 | RESPONSE TO INTERLEUKIN 1 | 9 | 115 | 4.738e-07 | 6.227e-06 |
355 | REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 12 | 232 | 5.288e-07 | 6.931e-06 |
356 | CARDIAC MUSCLE CELL ACTION POTENTIAL | 6 | 37 | 5.415e-07 | 7.077e-06 |
357 | REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 10 | 152 | 5.449e-07 | 7.102e-06 |
358 | POSITIVE REGULATION OF DNA REPLICATION | 8 | 86 | 5.563e-07 | 7.19e-06 |
359 | REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 13 | 278 | 5.535e-07 | 7.19e-06 |
360 | POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 8 | 86 | 5.563e-07 | 7.19e-06 |
361 | TISSUE REMODELING | 8 | 87 | 6.084e-07 | 7.841e-06 |
362 | CHONDROCYTE DIFFERENTIATION | 7 | 60 | 6.124e-07 | 7.871e-06 |
363 | POSITIVE REGULATION OF ORGAN GROWTH | 6 | 38 | 6.386e-07 | 8.186e-06 |
364 | POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT | 13 | 282 | 6.505e-07 | 8.315e-06 |
365 | CELLULAR RESPONSE TO INTERLEUKIN 1 | 8 | 88 | 6.645e-07 | 8.425e-06 |
366 | POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 8 | 88 | 6.645e-07 | 8.425e-06 |
367 | REGULATION OF CATION CHANNEL ACTIVITY | 8 | 88 | 6.645e-07 | 8.425e-06 |
368 | PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS | 9 | 120 | 6.802e-07 | 8.6e-06 |
369 | POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 10 | 156 | 6.924e-07 | 8.73e-06 |
370 | POSITIVE REGULATION OF CELL CYCLE | 14 | 332 | 6.945e-07 | 8.734e-06 |
371 | REGULATION OF PHOSPHOLIPASE C ACTIVITY | 6 | 39 | 7.496e-07 | 9.37e-06 |
372 | POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 6 | 39 | 7.496e-07 | 9.37e-06 |
373 | REGULATION OF CELLULAR PROTEIN LOCALIZATION | 18 | 552 | 7.512e-07 | 9.37e-06 |
374 | REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 6 | 40 | 8.759e-07 | 1.087e-05 |
375 | SECOND MESSENGER MEDIATED SIGNALING | 10 | 160 | 8.736e-07 | 1.087e-05 |
376 | SKELETAL SYSTEM MORPHOGENESIS | 11 | 201 | 9.181e-07 | 1.136e-05 |
377 | REGULATION OF DNA METABOLIC PROCESS | 14 | 340 | 9.219e-07 | 1.138e-05 |
378 | REGULATION OF HOMEOSTATIC PROCESS | 16 | 447 | 9.6e-07 | 1.182e-05 |
379 | RESPONSE TO UV | 9 | 126 | 1.027e-06 | 1.261e-05 |
380 | POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 13 | 296 | 1.121e-06 | 1.372e-05 |
381 | MUSCLE CELL DEVELOPMENT | 9 | 128 | 1.172e-06 | 1.432e-05 |
382 | POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 6 | 42 | 1.181e-06 | 1.438e-05 |
383 | REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS | 8 | 95 | 1.197e-06 | 1.454e-05 |
384 | CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM | 12 | 252 | 1.267e-06 | 1.535e-05 |
385 | REGULATION OF PEPTIDE SECRETION | 11 | 209 | 1.347e-06 | 1.628e-05 |
386 | REGULATION OF PROTEIN BINDING | 10 | 168 | 1.364e-06 | 1.644e-05 |
387 | RESPONSE TO OXIDATIVE STRESS | 14 | 352 | 1.389e-06 | 1.67e-05 |
388 | POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 4 | 11 | 1.409e-06 | 1.685e-05 |
389 | ACTIVATION OF MAPKKK ACTIVITY | 4 | 11 | 1.409e-06 | 1.685e-05 |
390 | LEARNING | 9 | 131 | 1.423e-06 | 1.698e-05 |
391 | GLYCEROLIPID BIOSYNTHETIC PROCESS | 11 | 211 | 1.479e-06 | 1.76e-05 |
392 | METAL ION TRANSPORT | 18 | 582 | 1.598e-06 | 1.896e-05 |
393 | GROWTH | 15 | 410 | 1.629e-06 | 1.928e-05 |
394 | STRIATED MUSCLE CONTRACTION | 8 | 99 | 1.639e-06 | 1.936e-05 |
395 | HISTONE PHOSPHORYLATION | 5 | 25 | 1.672e-06 | 1.97e-05 |
396 | REGULATION OF HOMOTYPIC CELL CELL ADHESION | 13 | 307 | 1.682e-06 | 1.976e-05 |
397 | LUNG MORPHOGENESIS | 6 | 45 | 1.796e-06 | 2.105e-05 |
398 | CELL GROWTH | 9 | 135 | 1.83e-06 | 2.139e-05 |
399 | IN UTERO EMBRYONIC DEVELOPMENT | 13 | 311 | 1.941e-06 | 2.263e-05 |
400 | GLIAL CELL DIFFERENTIATION | 9 | 136 | 1.946e-06 | 2.263e-05 |
401 | GLIOGENESIS | 10 | 175 | 1.974e-06 | 2.291e-05 |
402 | CELLULAR RESPONSE TO EXTERNAL STIMULUS | 12 | 264 | 2.059e-06 | 2.366e-05 |
403 | AGING | 12 | 264 | 2.059e-06 | 2.366e-05 |
404 | REGULATION OF P38MAPK CASCADE | 5 | 26 | 2.056e-06 | 2.366e-05 |
405 | EMBRYONIC CRANIAL SKELETON MORPHOGENESIS | 6 | 46 | 2.052e-06 | 2.366e-05 |
406 | REGULATION OF HEMOPOIESIS | 13 | 314 | 2.158e-06 | 2.473e-05 |
407 | REGULATION OF MUSCLE TISSUE DEVELOPMENT | 8 | 103 | 2.214e-06 | 2.525e-05 |
408 | REGULATION OF MUSCLE ORGAN DEVELOPMENT | 8 | 103 | 2.214e-06 | 2.525e-05 |
409 | REGULATION OF IMMUNE EFFECTOR PROCESS | 15 | 424 | 2.461e-06 | 2.8e-05 |
410 | POSITIVE REGULATION OF HEART GROWTH | 5 | 27 | 2.507e-06 | 2.838e-05 |
411 | POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 5 | 27 | 2.507e-06 | 2.838e-05 |
412 | REGULATION OF LIPID KINASE ACTIVITY | 6 | 48 | 2.652e-06 | 2.995e-05 |
413 | MULTICELLULAR ORGANISMAL HOMEOSTASIS | 12 | 272 | 2.805e-06 | 3.16e-05 |
414 | PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION | 4 | 13 | 3.014e-06 | 3.379e-05 |
415 | EYELID DEVELOPMENT IN CAMERA TYPE EYE | 4 | 13 | 3.014e-06 | 3.379e-05 |
416 | CELLULAR HOMEOSTASIS | 19 | 676 | 3.282e-06 | 3.671e-05 |
417 | REGULATION OF CELL CELL ADHESION | 14 | 380 | 3.39e-06 | 3.782e-05 |
418 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 15 | 437 | 3.557e-06 | 3.959e-05 |
419 | REGULATION OF LEUKOCYTE DIFFERENTIATION | 11 | 232 | 3.709e-06 | 4.109e-05 |
420 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 11 | 232 | 3.709e-06 | 4.109e-05 |
421 | REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 6 | 51 | 3.813e-06 | 4.214e-05 |
422 | PROTEIN LOCALIZATION | 34 | 1805 | 3.882e-06 | 4.28e-05 |
423 | POSITIVE REGULATION OF CELL GROWTH | 9 | 148 | 3.915e-06 | 4.307e-05 |
424 | BONE MORPHOGENESIS | 7 | 79 | 4.031e-06 | 4.423e-05 |
425 | MUSCLE SYSTEM PROCESS | 12 | 282 | 4.066e-06 | 4.451e-05 |
426 | RESPONSE TO METAL ION | 13 | 333 | 4.107e-06 | 4.486e-05 |
427 | TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 10 | 190 | 4.128e-06 | 4.499e-05 |
428 | PHOSPHOLIPID BIOSYNTHETIC PROCESS | 11 | 235 | 4.196e-06 | 4.561e-05 |
429 | REGULATION OF HEART RATE BY CARDIAC CONDUCTION | 5 | 30 | 4.338e-06 | 4.683e-05 |
430 | MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 5 | 30 | 4.338e-06 | 4.683e-05 |
431 | RESPONSE TO REACTIVE OXYGEN SPECIES | 10 | 191 | 4.326e-06 | 4.683e-05 |
432 | POSITIVE REGULATION OF ION TRANSPORT | 11 | 236 | 4.37e-06 | 4.707e-05 |
433 | OVULATION CYCLE | 8 | 113 | 4.444e-06 | 4.776e-05 |
434 | RESPONSE TO HORMONE | 22 | 893 | 4.464e-06 | 4.786e-05 |
435 | REGULATION OF BODY FLUID LEVELS | 16 | 506 | 4.74e-06 | 5.07e-05 |
436 | POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 6 | 53 | 4.795e-06 | 5.117e-05 |
437 | REGULATION OF PEPTIDASE ACTIVITY | 14 | 392 | 4.847e-06 | 5.161e-05 |
438 | SINGLE ORGANISM CELLULAR LOCALIZATION | 22 | 898 | 4.88e-06 | 5.184e-05 |
439 | CELL PART MORPHOGENESIS | 18 | 633 | 5.158e-06 | 5.467e-05 |
440 | CELL CYCLE ARREST | 9 | 154 | 5.421e-06 | 5.733e-05 |
441 | MULTICELLULAR ORGANISM REPRODUCTION | 20 | 768 | 5.589e-06 | 5.896e-05 |
442 | CYTOSKELETON ORGANIZATION | 21 | 838 | 5.787e-06 | 6.082e-05 |
443 | SKELETAL SYSTEM DEVELOPMENT | 15 | 455 | 5.79e-06 | 6.082e-05 |
444 | EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 6 | 55 | 5.973e-06 | 6.245e-05 |
445 | REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 6 | 55 | 5.973e-06 | 6.245e-05 |
446 | ESTABLISHMENT OF LOCALIZATION IN CELL | 32 | 1676 | 6.009e-06 | 6.269e-05 |
447 | NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 5 | 32 | 6.048e-06 | 6.282e-05 |
448 | NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 5 | 32 | 6.048e-06 | 6.282e-05 |
449 | REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 8 | 118 | 6.135e-06 | 6.358e-05 |
450 | REGULATION OF ENDOCYTOSIS | 10 | 199 | 6.223e-06 | 6.435e-05 |
451 | TOLL LIKE RECEPTOR SIGNALING PATHWAY | 7 | 85 | 6.585e-06 | 6.779e-05 |
452 | HEART PROCESS | 7 | 85 | 6.585e-06 | 6.779e-05 |
453 | POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 6 | 56 | 6.644e-06 | 6.825e-05 |
454 | UROGENITAL SYSTEM DEVELOPMENT | 12 | 299 | 7.376e-06 | 7.56e-05 |
455 | POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 4 | 16 | 7.524e-06 | 7.695e-05 |
456 | REPRODUCTIVE SYSTEM DEVELOPMENT | 14 | 408 | 7.645e-06 | 7.801e-05 |
457 | REGULATION OF DNA REPLICATION | 9 | 161 | 7.782e-06 | 7.923e-05 |
458 | OSSIFICATION | 11 | 251 | 7.853e-06 | 7.978e-05 |
459 | FOREBRAIN NEURON DEVELOPMENT | 5 | 34 | 8.247e-06 | 8.288e-05 |
460 | RESPONSE TO FLUID SHEAR STRESS | 5 | 34 | 8.247e-06 | 8.288e-05 |
461 | NUCLEAR TRANSPORT | 13 | 355 | 8.192e-06 | 8.288e-05 |
462 | ORGAN FORMATION | 5 | 34 | 8.247e-06 | 8.288e-05 |
463 | REGULATION OF MESENCHYMAL CELL PROLIFERATION | 5 | 34 | 8.247e-06 | 8.288e-05 |
464 | OVULATION CYCLE PROCESS | 7 | 88 | 8.296e-06 | 8.301e-05 |
465 | REGULATION OF STEM CELL PROLIFERATION | 7 | 88 | 8.296e-06 | 8.301e-05 |
466 | EPIDERMIS DEVELOPMENT | 11 | 253 | 8.464e-06 | 8.451e-05 |
467 | CELLULAR RESPONSE TO BIOTIC STIMULUS | 9 | 163 | 8.6e-06 | 8.568e-05 |
468 | FOREBRAIN DEVELOPMENT | 13 | 357 | 8.7e-06 | 8.65e-05 |
469 | POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 6 | 59 | 9.034e-06 | 8.963e-05 |
470 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 12 | 306 | 9.314e-06 | 9.221e-05 |
471 | ACTIVATION OF JUN KINASE ACTIVITY | 5 | 35 | 9.557e-06 | 9.422e-05 |
472 | BONE REMODELING | 5 | 35 | 9.557e-06 | 9.422e-05 |
473 | REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 4 | 17 | 9.777e-06 | 9.617e-05 |
474 | CELL CYCLE | 27 | 1316 | 1.013e-05 | 9.941e-05 |
475 | SKIN DEVELOPMENT | 10 | 211 | 1.041e-05 | 0.0001017 |
476 | NEGATIVE REGULATION OF CYTOKINE PRODUCTION | 10 | 211 | 1.041e-05 | 0.0001017 |
477 | POSITIVE REGULATION OF BINDING | 8 | 127 | 1.056e-05 | 0.000103 |
478 | CHEMICAL HOMEOSTASIS | 21 | 874 | 1.097e-05 | 0.0001064 |
479 | REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 6 | 61 | 1.098e-05 | 0.0001064 |
480 | POSITIVE REGULATION OF CELL ACTIVATION | 12 | 311 | 1.096e-05 | 0.0001064 |
481 | CELLULAR RESPONSE TO HEAT | 5 | 36 | 1.103e-05 | 0.0001064 |
482 | POSITIVE REGULATION OF PROTEIN ACETYLATION | 5 | 36 | 1.103e-05 | 0.0001064 |
483 | REGULATION OF HORMONE SECRETION | 11 | 262 | 1.176e-05 | 0.0001133 |
484 | REGULATION OF REPRODUCTIVE PROCESS | 8 | 129 | 1.184e-05 | 0.0001138 |
485 | CELLULAR RESPONSE TO ABIOTIC STIMULUS | 11 | 263 | 1.218e-05 | 0.0001169 |
486 | CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION | 5 | 37 | 1.266e-05 | 0.0001212 |
487 | POSITIVE REGULATION OF SECRETION | 13 | 370 | 1.273e-05 | 0.0001216 |
488 | REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS | 7 | 94 | 1.283e-05 | 0.0001221 |
489 | REGULATION OF DNA BIOSYNTHETIC PROCESS | 7 | 94 | 1.283e-05 | 0.0001221 |
490 | ESTABLISHMENT OF PROTEIN LOCALIZATION | 28 | 1423 | 1.468e-05 | 0.0001394 |
491 | NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 18 | 684 | 1.476e-05 | 0.0001399 |
492 | NEGATIVE REGULATION OF CELL CYCLE | 14 | 433 | 1.491e-05 | 0.0001411 |
493 | POSITIVE REGULATION OF CELL ADHESION | 13 | 376 | 1.509e-05 | 0.0001424 |
494 | HOMEOSTASIS OF NUMBER OF CELLS | 9 | 175 | 1.522e-05 | 0.0001434 |
495 | RESPONSE TO MUSCLE STRETCH | 4 | 19 | 1.572e-05 | 0.0001475 |
496 | NEGATIVE REGULATION OF MEIOTIC CELL CYCLE | 4 | 19 | 1.572e-05 | 0.0001475 |
497 | WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY | 5 | 39 | 1.651e-05 | 0.0001542 |
498 | ERBB2 SIGNALING PATHWAY | 5 | 39 | 1.651e-05 | 0.0001542 |
499 | POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 6 | 67 | 1.895e-05 | 0.0001763 |
500 | CELLULAR RESPONSE TO DRUG | 6 | 67 | 1.895e-05 | 0.0001763 |
501 | TRACHEA DEVELOPMENT | 4 | 20 | 1.952e-05 | 0.0001809 |
502 | PROTEIN REFOLDING | 4 | 20 | 1.952e-05 | 0.0001809 |
503 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 15 | 505 | 1.985e-05 | 0.0001836 |
504 | RESPONSE TO ORGANOPHOSPHORUS | 8 | 139 | 2.04e-05 | 0.000188 |
505 | REGULATION OF CHROMOSOME ORGANIZATION | 11 | 278 | 2.04e-05 | 0.000188 |
506 | EMBRYONIC ORGAN MORPHOGENESIS | 11 | 279 | 2.109e-05 | 0.000194 |
507 | DEVELOPMENTAL GROWTH | 12 | 333 | 2.16e-05 | 0.0001983 |
508 | REGULATION OF MYELOID CELL DIFFERENTIATION | 9 | 183 | 2.172e-05 | 0.0001989 |
509 | NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 7 | 102 | 2.191e-05 | 0.0002003 |
510 | POSITIVE REGULATION OF AXONOGENESIS | 6 | 69 | 2.246e-05 | 0.0002049 |
511 | REGULATION OF CELL GROWTH | 13 | 391 | 2.274e-05 | 0.0002071 |
512 | CELL JUNCTION ORGANIZATION | 9 | 185 | 2.367e-05 | 0.0002151 |
513 | NEGATIVE REGULATION OF ORGAN GROWTH | 4 | 21 | 2.396e-05 | 0.0002173 |
514 | CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 6 | 70 | 2.439e-05 | 0.0002208 |
515 | RESPONSE TO TUMOR NECROSIS FACTOR | 10 | 233 | 2.454e-05 | 0.0002217 |
516 | RESPONSE TO CAMP | 7 | 104 | 2.486e-05 | 0.0002238 |
517 | DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 7 | 104 | 2.486e-05 | 0.0002238 |
518 | CEREBRAL CORTEX DEVELOPMENT | 7 | 105 | 2.645e-05 | 0.0002373 |
519 | SKIN EPIDERMIS DEVELOPMENT | 6 | 71 | 2.647e-05 | 0.0002373 |
520 | INORGANIC ION TRANSMEMBRANE TRANSPORT | 16 | 583 | 2.732e-05 | 0.0002444 |
521 | SYNAPSE ORGANIZATION | 8 | 145 | 2.767e-05 | 0.0002471 |
522 | POSITIVE REGULATION OF CALCIUM ION TRANSPORT | 7 | 106 | 2.813e-05 | 0.0002508 |
523 | CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION | 4 | 22 | 2.91e-05 | 0.0002584 |
524 | SOMATIC STEM CELL DIVISION | 4 | 22 | 2.91e-05 | 0.0002584 |
525 | MESENCHYME DEVELOPMENT | 9 | 190 | 2.921e-05 | 0.0002589 |
526 | DIGESTIVE SYSTEM DEVELOPMENT | 8 | 148 | 3.206e-05 | 0.0002836 |
527 | RESPONSE TO TOXIC SUBSTANCE | 10 | 241 | 3.272e-05 | 0.0002889 |
528 | POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 13 | 406 | 3.361e-05 | 0.0002962 |
529 | REGULATION OF ORGAN MORPHOGENESIS | 10 | 242 | 3.389e-05 | 0.0002981 |
530 | POSITIVE REGULATION OF CHROMOSOME ORGANIZATION | 8 | 150 | 3.529e-05 | 0.0003098 |
531 | NEURON MIGRATION | 7 | 110 | 3.573e-05 | 0.0003131 |
532 | PALLIUM DEVELOPMENT | 8 | 153 | 4.065e-05 | 0.0003555 |
533 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 18 | 740 | 4.16e-05 | 0.0003631 |
534 | POSITIVE REGULATION OF RECEPTOR INTERNALIZATION | 4 | 24 | 4.173e-05 | 0.0003636 |
535 | ORGANOPHOSPHATE METABOLIC PROCESS | 20 | 885 | 4.299e-05 | 0.0003739 |
536 | REGULATION OF HORMONE LEVELS | 14 | 478 | 4.413e-05 | 0.0003831 |
537 | POSITIVE REGULATION OF ENDOCYTOSIS | 7 | 114 | 4.495e-05 | 0.0003888 |
538 | REGULATION OF EMBRYONIC DEVELOPMENT | 7 | 114 | 4.495e-05 | 0.0003888 |
539 | BONE DEVELOPMENT | 8 | 156 | 4.667e-05 | 0.0004029 |
540 | NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 7 | 115 | 4.754e-05 | 0.0004096 |
541 | EPITHELIAL CELL APOPTOTIC PROCESS | 4 | 25 | 4.936e-05 | 0.0004229 |
542 | POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 4 | 25 | 4.936e-05 | 0.0004229 |
543 | THYROID GLAND DEVELOPMENT | 4 | 25 | 4.936e-05 | 0.0004229 |
544 | RESPONSE TO PURINE CONTAINING COMPOUND | 8 | 158 | 5.108e-05 | 0.0004369 |
545 | CELLULAR RESPONSE TO HORMONE STIMULUS | 15 | 552 | 5.5e-05 | 0.0004696 |
546 | REGULATION OF FIBROBLAST PROLIFERATION | 6 | 81 | 5.604e-05 | 0.0004775 |
547 | LYMPHOCYTE HOMEOSTASIS | 5 | 50 | 5.645e-05 | 0.0004785 |
548 | RESPONSE TO PROGESTERONE | 5 | 50 | 5.645e-05 | 0.0004785 |
549 | REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 5 | 50 | 5.645e-05 | 0.0004785 |
550 | POSITIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS | 5 | 51 | 6.218e-05 | 0.000525 |
551 | REGULATION OF NEUROTRANSMITTER SECRETION | 5 | 51 | 6.218e-05 | 0.000525 |
552 | NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS | 12 | 372 | 6.325e-05 | 0.0005331 |
553 | POSITIVE REGULATION OF HEMOPOIESIS | 8 | 163 | 6.366e-05 | 0.0005356 |
554 | HAIR CYCLE | 6 | 83 | 6.429e-05 | 0.0005381 |
555 | EMBRYONIC PLACENTA DEVELOPMENT | 6 | 83 | 6.429e-05 | 0.0005381 |
556 | MOLTING CYCLE | 6 | 83 | 6.429e-05 | 0.0005381 |
557 | REGULATION OF PROTEIN KINASE B SIGNALING | 7 | 121 | 6.573e-05 | 0.0005491 |
558 | NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 10 | 262 | 6.61e-05 | 0.0005502 |
559 | POSITIVE REGULATION OF PROTEIN SECRETION | 9 | 211 | 6.604e-05 | 0.0005502 |
560 | REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 4 | 27 | 6.76e-05 | 0.0005607 |
561 | REGULATION OF FATTY ACID TRANSPORT | 4 | 27 | 6.76e-05 | 0.0005607 |
562 | NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE | 5 | 52 | 6.833e-05 | 0.0005648 |
563 | REGULATION OF PROTEIN COMPLEX ASSEMBLY | 12 | 375 | 6.828e-05 | 0.0005648 |
564 | NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH | 6 | 84 | 6.877e-05 | 0.0005674 |
565 | EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 7 | 122 | 6.926e-05 | 0.0005704 |
566 | RESPONSE TO ACID CHEMICAL | 11 | 319 | 7.12e-05 | 0.0005853 |
567 | REGULATION OF ADAPTIVE IMMUNE RESPONSE | 7 | 123 | 7.293e-05 | 0.0005964 |
568 | POSITIVE REGULATION OF MITOTIC CELL CYCLE | 7 | 123 | 7.293e-05 | 0.0005964 |
569 | ENDOCRINE SYSTEM DEVELOPMENT | 7 | 123 | 7.293e-05 | 0.0005964 |
570 | REGULATION OF CYTOSKELETON ORGANIZATION | 14 | 502 | 7.459e-05 | 0.0006089 |
571 | REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE | 5 | 53 | 7.495e-05 | 0.0006097 |
572 | POSITIVE REGULATION OF FIBROBLAST PROLIFERATION | 5 | 53 | 7.495e-05 | 0.0006097 |
573 | POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 4 | 28 | 7.836e-05 | 0.0006339 |
574 | NECROTIC CELL DEATH | 4 | 28 | 7.836e-05 | 0.0006339 |
575 | REGULATION OF FIBROBLAST MIGRATION | 4 | 28 | 7.836e-05 | 0.0006339 |
576 | REGULATION OF HEART RATE | 6 | 86 | 7.847e-05 | 0.0006339 |
577 | REGULATION OF AXONOGENESIS | 8 | 168 | 7.871e-05 | 0.0006347 |
578 | POSITIVE REGULATION OF HOMEOSTATIC PROCESS | 9 | 216 | 7.906e-05 | 0.0006364 |
579 | KIDNEY EPITHELIUM DEVELOPMENT | 7 | 125 | 8.076e-05 | 0.000649 |
580 | CELL CYCLE PROCESS | 22 | 1081 | 8.274e-05 | 0.0006638 |
581 | RESPONSE TO ESTROGEN | 9 | 218 | 8.483e-05 | 0.0006794 |
582 | GLUCOSE HOMEOSTASIS | 8 | 170 | 8.55e-05 | 0.0006824 |
583 | CARBOHYDRATE HOMEOSTASIS | 8 | 170 | 8.55e-05 | 0.0006824 |
584 | NEUROLOGICAL SYSTEM PROCESS | 24 | 1242 | 8.586e-05 | 0.0006841 |
585 | POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 3 | 11 | 8.666e-05 | 0.0006881 |
586 | POSITIVE REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS | 3 | 11 | 8.666e-05 | 0.0006881 |
587 | TISSUE HOMEOSTASIS | 8 | 171 | 8.908e-05 | 0.0007061 |
588 | STEM CELL DIVISION | 4 | 29 | 9.031e-05 | 0.0007135 |
589 | CARDIAC MUSCLE CELL CONTRACTION | 4 | 29 | 9.031e-05 | 0.0007135 |
590 | REGULATION OF PROTEIN STABILITY | 9 | 221 | 9.416e-05 | 0.0007426 |
591 | EPITHELIAL CELL PROLIFERATION | 6 | 89 | 9.504e-05 | 0.0007482 |
592 | SMAD PROTEIN SIGNAL TRANSDUCTION | 5 | 56 | 9.78e-05 | 0.0007674 |
593 | NEURON NEURON SYNAPTIC TRANSMISSION | 5 | 56 | 9.78e-05 | 0.0007674 |
594 | NUCLEAR IMPORT | 7 | 129 | 9.848e-05 | 0.0007715 |
595 | MUSCLE TISSUE DEVELOPMENT | 10 | 275 | 9.872e-05 | 0.000772 |
596 | MESONEPHROS DEVELOPMENT | 6 | 90 | 0.0001011 | 0.0007896 |
597 | CATION TRANSPORT | 18 | 796 | 0.0001054 | 0.0008217 |
598 | REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 5 | 57 | 0.0001065 | 0.0008286 |
599 | POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION | 7 | 131 | 0.0001085 | 0.0008425 |
600 | SECRETION | 15 | 588 | 0.0001112 | 0.0008621 |
601 | NEGATIVE REGULATION OF TRANSPORT | 13 | 458 | 0.0001139 | 0.0008815 |
602 | REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 3 | 12 | 0.0001148 | 0.0008833 |
603 | POSITIVE REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS | 3 | 12 | 0.0001148 | 0.0008833 |
604 | I KAPPAB PHOSPHORYLATION | 3 | 12 | 0.0001148 | 0.0008833 |
605 | TRACHEA MORPHOGENESIS | 3 | 12 | 0.0001148 | 0.0008833 |
606 | POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS | 5 | 58 | 0.0001158 | 0.0008889 |
607 | ADULT WALKING BEHAVIOR | 4 | 31 | 0.0001181 | 0.0008995 |
608 | POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 4 | 31 | 0.0001181 | 0.0008995 |
609 | LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 4 | 31 | 0.0001181 | 0.0008995 |
610 | POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 4 | 31 | 0.0001181 | 0.0008995 |
611 | WALKING BEHAVIOR | 4 | 31 | 0.0001181 | 0.0008995 |
612 | NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS | 27 | 1517 | 0.0001187 | 0.0009022 |
613 | TELENCEPHALON DEVELOPMENT | 9 | 228 | 0.0001193 | 0.0009057 |
614 | EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS | 6 | 93 | 0.0001213 | 0.0009181 |
615 | REGULATION OF LIPID METABOLIC PROCESS | 10 | 282 | 0.0001213 | 0.0009181 |
616 | MESENCHYMAL CELL DIFFERENTIATION | 7 | 134 | 0.000125 | 0.0009439 |
617 | REGULATION OF GLIAL CELL DIFFERENTIATION | 5 | 59 | 0.0001257 | 0.0009476 |
618 | PATTERNING OF BLOOD VESSELS | 4 | 32 | 0.0001341 | 0.00101 |
619 | DIVALENT INORGANIC CATION HOMEOSTASIS | 11 | 343 | 0.0001352 | 0.001016 |
620 | POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 5 | 60 | 0.0001362 | 0.00102 |
621 | LEUKOCYTE HOMEOSTASIS | 5 | 60 | 0.0001362 | 0.00102 |
622 | RESPONSE TO KETONE | 8 | 182 | 0.0001373 | 0.001027 |
623 | MUSCLE CONTRACTION | 9 | 233 | 0.0001406 | 0.00105 |
624 | REGULATION OF MITOTIC CELL CYCLE | 13 | 468 | 0.000141 | 0.001051 |
625 | CARDIOCYTE DIFFERENTIATION | 6 | 96 | 0.0001446 | 0.001076 |
626 | NEURONAL STEM CELL DIVISION | 3 | 13 | 0.0001484 | 0.001091 |
627 | REGULATION OF PROSTAGLANDIN SECRETION | 3 | 13 | 0.0001484 | 0.001091 |
628 | REGULATION OF INTERLEUKIN 8 PRODUCTION | 5 | 61 | 0.0001474 | 0.001091 |
629 | HEPATOCYTE APOPTOTIC PROCESS | 3 | 13 | 0.0001484 | 0.001091 |
630 | REGULATION OF HISTONE PHOSPHORYLATION | 3 | 13 | 0.0001484 | 0.001091 |
631 | NEUROBLAST DIVISION | 3 | 13 | 0.0001484 | 0.001091 |
632 | POSITIVE REGULATION OF STEM CELL PROLIFERATION | 5 | 61 | 0.0001474 | 0.001091 |
633 | CELLULAR RESPONSE TO OXIDATIVE STRESS | 8 | 184 | 0.000148 | 0.001091 |
634 | PLACENTA DEVELOPMENT | 7 | 138 | 0.0001501 | 0.001101 |
635 | EMBRYONIC DIGESTIVE TRACT DEVELOPMENT | 4 | 33 | 0.0001517 | 0.001108 |
636 | SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 4 | 33 | 0.0001517 | 0.001108 |
637 | EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 4 | 33 | 0.0001517 | 0.001108 |
638 | CELLULAR RESPONSE TO CYTOKINE STIMULUS | 15 | 606 | 0.0001546 | 0.001128 |
639 | FOREBRAIN CELL MIGRATION | 5 | 62 | 0.0001592 | 0.001158 |
640 | POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 5 | 62 | 0.0001592 | 0.001158 |
641 | REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 6 | 98 | 0.000162 | 0.001176 |
642 | NON CANONICAL WNT SIGNALING PATHWAY | 7 | 140 | 0.0001641 | 0.001189 |
643 | POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 4 | 34 | 0.0001708 | 0.001236 |
644 | REGULATION OF CARTILAGE DEVELOPMENT | 5 | 63 | 0.0001718 | 0.001241 |
645 | MYELOID CELL DIFFERENTIATION | 8 | 189 | 0.0001779 | 0.001283 |
646 | STEM CELL DIFFERENTIATION | 8 | 190 | 0.0001845 | 0.001329 |
647 | REGULATION OF NEUROTRANSMITTER TRANSPORT | 5 | 64 | 0.0001851 | 0.001329 |
648 | REGULATION OF PROTEIN ACETYLATION | 5 | 64 | 0.0001851 | 0.001329 |
649 | REGULATION OF RESPIRATORY BURST | 3 | 14 | 0.0001877 | 0.001338 |
650 | VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 3 | 14 | 0.0001877 | 0.001338 |
651 | POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 3 | 14 | 0.0001877 | 0.001338 |
652 | RESPONSE TO LAMINAR FLUID SHEAR STRESS | 3 | 14 | 0.0001877 | 0.001338 |
653 | NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT | 7 | 143 | 0.0001871 | 0.001338 |
654 | POSITIVE REGULATION OF CELL CELL ADHESION | 9 | 243 | 0.0001926 | 0.00137 |
655 | CALCIUM ION IMPORT | 5 | 65 | 0.0001992 | 0.001415 |
656 | SECRETION BY CELL | 13 | 486 | 0.000204 | 0.001447 |
657 | NEGATIVE REGULATION OF PEPTIDASE ACTIVITY | 9 | 245 | 0.0002047 | 0.00145 |
658 | NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 5 | 66 | 0.0002141 | 0.001505 |
659 | ACID SECRETION | 5 | 66 | 0.0002141 | 0.001505 |
660 | FOREBRAIN GENERATION OF NEURONS | 5 | 66 | 0.0002141 | 0.001505 |
661 | NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 5 | 66 | 0.0002141 | 0.001505 |
662 | HEAD MORPHOGENESIS | 4 | 36 | 0.0002141 | 0.001505 |
663 | EAR DEVELOPMENT | 8 | 195 | 0.0002202 | 0.001545 |
664 | NEGATIVE REGULATION OF GENE EXPRESSION | 26 | 1493 | 0.0002275 | 0.001594 |
665 | REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 5 | 67 | 0.0002299 | 0.001608 |
666 | NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS | 3 | 15 | 0.0002332 | 0.001627 |
667 | NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 3 | 15 | 0.0002332 | 0.001627 |
668 | REGULATION OF RECEPTOR INTERNALIZATION | 4 | 37 | 0.0002386 | 0.001662 |
669 | REGULATION OF CELL JUNCTION ASSEMBLY | 5 | 68 | 0.0002465 | 0.001707 |
670 | MULTICELLULAR ORGANISMAL RESPONSE TO STRESS | 5 | 68 | 0.0002465 | 0.001707 |
671 | ORGAN GROWTH | 5 | 68 | 0.0002465 | 0.001707 |
672 | POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 5 | 68 | 0.0002465 | 0.001707 |
673 | RESPONSE TO STEROID HORMONE | 13 | 497 | 0.0002533 | 0.001751 |
674 | INTRACELLULAR PROTEIN TRANSPORT | 17 | 781 | 0.0002587 | 0.001786 |
675 | PROTEIN LOCALIZATION TO CELL PERIPHERY | 7 | 151 | 0.0002613 | 0.001801 |
676 | REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS | 4 | 38 | 0.0002649 | 0.001824 |
677 | RESPONSE TO OXYGEN LEVELS | 10 | 311 | 0.0002675 | 0.001838 |
678 | REGULATION OF MUSCLE CELL DIFFERENTIATION | 7 | 152 | 0.000272 | 0.001867 |
679 | REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 6 | 108 | 0.0002752 | 0.001886 |
680 | REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS | 3 | 16 | 0.0002853 | 0.001941 |
681 | CARDIAC MYOFIBRIL ASSEMBLY | 3 | 16 | 0.0002853 | 0.001941 |
682 | POSITIVE REGULATION OF TELOMERE CAPPING | 3 | 16 | 0.0002853 | 0.001941 |
683 | REGULATION OF INCLUSION BODY ASSEMBLY | 3 | 16 | 0.0002853 | 0.001941 |
684 | BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 3 | 16 | 0.0002853 | 0.001941 |
685 | REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 8 | 203 | 0.000289 | 0.001959 |
686 | REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 6 | 109 | 0.0002892 | 0.001959 |
687 | RESPONSE TO HYDROGEN PEROXIDE | 6 | 109 | 0.0002892 | 0.001959 |
688 | ASTROCYTE DIFFERENTIATION | 4 | 39 | 0.0002933 | 0.001981 |
689 | EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 4 | 39 | 0.0002933 | 0.001981 |
690 | POSITIVE REGULATION OF PEPTIDASE ACTIVITY | 7 | 154 | 0.0002946 | 0.001986 |
691 | PROTEIN LOCALIZATION TO MEMBRANE | 11 | 376 | 0.0002984 | 0.00201 |
692 | FORMATION OF PRIMARY GERM LAYER | 6 | 110 | 0.0003039 | 0.002043 |
693 | PROTEIN IMPORT | 7 | 155 | 0.0003064 | 0.002054 |
694 | GASTRULATION | 7 | 155 | 0.0003064 | 0.002054 |
695 | NEURON PROJECTION GUIDANCE | 8 | 205 | 0.0003087 | 0.002067 |
696 | CELLULAR RESPONSE TO INORGANIC SUBSTANCE | 7 | 156 | 0.0003186 | 0.002124 |
697 | REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 7 | 156 | 0.0003186 | 0.002124 |
698 | PROTEIN LOCALIZATION TO NUCLEUS | 7 | 156 | 0.0003186 | 0.002124 |
699 | REGULATION OF MEIOTIC CELL CYCLE | 4 | 40 | 0.0003238 | 0.002156 |
700 | POSITIVE REGULATION OF PROTEIN BINDING | 5 | 73 | 0.0003436 | 0.002276 |
701 | REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS | 3 | 17 | 0.0003444 | 0.002276 |
702 | BRANCH ELONGATION OF AN EPITHELIUM | 3 | 17 | 0.0003444 | 0.002276 |
703 | PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING | 3 | 17 | 0.0003444 | 0.002276 |
704 | POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 3 | 17 | 0.0003444 | 0.002276 |
705 | REGULATION OF STEM CELL DIFFERENTIATION | 6 | 113 | 0.0003513 | 0.002318 |
706 | NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE | 4 | 41 | 0.0003565 | 0.002347 |
707 | NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 4 | 41 | 0.0003565 | 0.002347 |
708 | REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 6 | 114 | 0.0003683 | 0.00242 |
709 | ORGANOPHOSPHATE BIOSYNTHETIC PROCESS | 12 | 450 | 0.0003691 | 0.002422 |
710 | NEPHRON DEVELOPMENT | 6 | 115 | 0.0003859 | 0.002526 |
711 | RESPONSE TO CALCIUM ION | 6 | 115 | 0.0003859 | 0.002526 |
712 | HEART MORPHOGENESIS | 8 | 212 | 0.0003865 | 0.002526 |
713 | NEGATIVE REGULATION OF PROTEOLYSIS | 10 | 329 | 0.0004171 | 0.002722 |
714 | MAMMARY GLAND DEVELOPMENT | 6 | 117 | 0.0004232 | 0.002758 |
715 | CEREBRAL CORTEX CELL MIGRATION | 4 | 43 | 0.000429 | 0.002792 |
716 | SINGLE ORGANISM CELL ADHESION | 12 | 459 | 0.0004405 | 0.002863 |
717 | CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 7 | 166 | 0.0004634 | 0.003007 |
718 | ION TRANSMEMBRANE TRANSPORT | 17 | 822 | 0.0004654 | 0.003016 |
719 | REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 5 | 78 | 0.0004672 | 0.003024 |
720 | BODY MORPHOGENESIS | 4 | 44 | 0.0004689 | 0.00303 |
721 | NEGATIVE REGULATION OF HYDROLASE ACTIVITY | 11 | 397 | 0.0004717 | 0.003044 |
722 | REGULATION OF ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLE PROPIONATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY | 3 | 19 | 0.0004848 | 0.00312 |
723 | POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 3 | 19 | 0.0004848 | 0.00312 |
724 | DENDRITE DEVELOPMENT | 5 | 79 | 0.0004955 | 0.003184 |
725 | INTRACELLULAR RECEPTOR SIGNALING PATHWAY | 7 | 168 | 0.0004978 | 0.003195 |
726 | NEGATIVE REGULATION OF IMMUNE RESPONSE | 6 | 121 | 0.0005062 | 0.003244 |
727 | ENDOCHONDRAL BONE MORPHOGENESIS | 4 | 45 | 0.0005113 | 0.003273 |
728 | ADULT LOCOMOTORY BEHAVIOR | 5 | 80 | 0.000525 | 0.003356 |
729 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 14 | 609 | 0.0005392 | 0.003442 |
730 | REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL | 9 | 280 | 0.0005434 | 0.003463 |
731 | INTRASPECIES INTERACTION BETWEEN ORGANISMS | 4 | 46 | 0.0005564 | 0.003527 |
732 | POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 5 | 81 | 0.0005559 | 0.003527 |
733 | SOCIAL BEHAVIOR | 4 | 46 | 0.0005564 | 0.003527 |
734 | POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING | 5 | 81 | 0.0005559 | 0.003527 |
735 | EMBRYONIC HEMOPOIESIS | 3 | 20 | 0.0005669 | 0.00357 |
736 | REGULATION OF ICOSANOID SECRETION | 3 | 20 | 0.0005669 | 0.00357 |
737 | REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 3 | 20 | 0.0005669 | 0.00357 |
738 | MICROVILLUS ORGANIZATION | 3 | 20 | 0.0005669 | 0.00357 |
739 | MYELOID DENDRITIC CELL DIFFERENTIATION | 3 | 20 | 0.0005669 | 0.00357 |
740 | KIDNEY MORPHOGENESIS | 5 | 82 | 0.0005881 | 0.003698 |
741 | POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 4 | 47 | 0.0006043 | 0.00379 |
742 | MUSCLE FIBER DEVELOPMENT | 4 | 47 | 0.0006043 | 0.00379 |
743 | ANATOMICAL STRUCTURE HOMEOSTASIS | 9 | 285 | 0.0006168 | 0.003863 |
744 | NIK NF KAPPAB SIGNALING | 5 | 83 | 0.0006217 | 0.003888 |
745 | NECROPTOTIC PROCESS | 3 | 21 | 0.0006574 | 0.004073 |
746 | POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 5 | 84 | 0.0006567 | 0.004073 |
747 | POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 4 | 48 | 0.0006551 | 0.004073 |
748 | NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 3 | 21 | 0.0006574 | 0.004073 |
749 | BONE RESORPTION | 3 | 21 | 0.0006574 | 0.004073 |
750 | REGULATION OF INTERLEUKIN 2 PRODUCTION | 4 | 48 | 0.0006551 | 0.004073 |
751 | POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION | 4 | 48 | 0.0006551 | 0.004073 |
752 | LEUKOCYTE ACTIVATION | 11 | 414 | 0.0006676 | 0.004131 |
753 | HEPATICOBILIARY SYSTEM DEVELOPMENT | 6 | 128 | 0.0006814 | 0.004211 |
754 | PALATE DEVELOPMENT | 5 | 85 | 0.0006931 | 0.004272 |
755 | POSITIVE REGULATION OF CHROMATIN MODIFICATION | 5 | 85 | 0.0006931 | 0.004272 |
756 | REGULATION OF OSSIFICATION | 7 | 178 | 0.0007019 | 0.00432 |
757 | CELLULAR RESPONSE TO CALCIUM ION | 4 | 49 | 0.0007087 | 0.004356 |
758 | ION TRANSPORT | 22 | 1262 | 0.000712 | 0.00437 |
759 | LEUKOCYTE DIFFERENTIATION | 9 | 292 | 0.0007331 | 0.004494 |
760 | NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 3 | 22 | 0.0007566 | 0.004614 |
761 | SYNAPTIC TRANSMISSION GLUTAMATERGIC | 3 | 22 | 0.0007566 | 0.004614 |
762 | REGULATION OF TELOMERE CAPPING | 3 | 22 | 0.0007566 | 0.004614 |
763 | REGULATION OF CELL CYCLE PROCESS | 13 | 558 | 0.0007537 | 0.004614 |
764 | REGULATION OF ORGANIC ACID TRANSPORT | 4 | 50 | 0.0007655 | 0.004644 |
765 | REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 4 | 50 | 0.0007655 | 0.004644 |
766 | POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 4 | 50 | 0.0007655 | 0.004644 |
767 | POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 4 | 50 | 0.0007655 | 0.004644 |
768 | PROTEIN STABILIZATION | 6 | 131 | 0.0007694 | 0.004662 |
769 | LOCOMOTORY BEHAVIOR | 7 | 181 | 0.0007745 | 0.004686 |
770 | NEGATIVE REGULATION OF GROWTH | 8 | 236 | 0.0007827 | 0.00473 |
771 | POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION | 4 | 51 | 0.0008253 | 0.004968 |
772 | ARTERY MORPHOGENESIS | 4 | 51 | 0.0008253 | 0.004968 |
773 | REGULATION OF INTERLEUKIN 12 PRODUCTION | 4 | 51 | 0.0008253 | 0.004968 |
774 | SENSORY ORGAN MORPHOGENESIS | 8 | 239 | 0.0008495 | 0.005107 |
775 | ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE | 10 | 361 | 0.0008538 | 0.005123 |
776 | EPITHELIAL CELL DIFFERENTIATION | 12 | 495 | 0.0008544 | 0.005123 |
777 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS | 3 | 23 | 0.0008649 | 0.005166 |
778 | PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING | 3 | 23 | 0.0008649 | 0.005166 |
779 | POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 3 | 23 | 0.0008649 | 0.005166 |
780 | MORPHOGENESIS OF EMBRYONIC EPITHELIUM | 6 | 134 | 0.000866 | 0.005166 |
781 | RESPONSE TO ALCOHOL | 10 | 362 | 0.0008719 | 0.005195 |
782 | REGULATION OF T CELL MEDIATED IMMUNITY | 4 | 52 | 0.0008884 | 0.005286 |
783 | REGULATION OF GLIOGENESIS | 5 | 90 | 0.0008985 | 0.005339 |
784 | NEGATIVE REGULATION OF CELL DEVELOPMENT | 9 | 303 | 0.0009515 | 0.005638 |
785 | MAMMARY GLAND EPITHELIUM DEVELOPMENT | 4 | 53 | 0.0009548 | 0.005638 |
786 | REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS | 4 | 53 | 0.0009548 | 0.005638 |
787 | CYTOSOLIC CALCIUM ION TRANSPORT | 4 | 53 | 0.0009548 | 0.005638 |
788 | NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION | 4 | 53 | 0.0009548 | 0.005638 |
789 | NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 3 | 24 | 0.0009825 | 0.005787 |
790 | RESPONSE TO STEROL | 3 | 24 | 0.0009825 | 0.005787 |
791 | ION HOMEOSTASIS | 13 | 576 | 0.001007 | 0.005924 |
792 | NEGATIVE REGULATION OF REPRODUCTIVE PROCESS | 4 | 54 | 0.001025 | 0.006012 |
793 | B CELL RECEPTOR SIGNALING PATHWAY | 4 | 54 | 0.001025 | 0.006012 |
794 | REGULATION OF NEUROTRANSMITTER LEVELS | 7 | 190 | 0.001029 | 0.006028 |
795 | RESPONSE TO VIRUS | 8 | 247 | 0.00105 | 0.006146 |
796 | CARDIAC MUSCLE TISSUE DEVELOPMENT | 6 | 140 | 0.001087 | 0.006355 |
797 | NEURAL TUBE FORMATION | 5 | 94 | 0.001093 | 0.006381 |
798 | REGULATION OF KIDNEY DEVELOPMENT | 4 | 55 | 0.001098 | 0.006394 |
799 | REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL | 4 | 55 | 0.001098 | 0.006394 |
800 | RESPONSE TO EXTRACELLULAR STIMULUS | 11 | 441 | 0.001115 | 0.006487 |
801 | DEVELOPMENTAL MATURATION | 7 | 193 | 0.001127 | 0.006544 |
802 | REGULATION OF ACTIN FILAMENT BASED PROCESS | 9 | 312 | 0.001167 | 0.006771 |
803 | EPITHELIAL TO MESENCHYMAL TRANSITION | 4 | 56 | 0.001175 | 0.006799 |
804 | OUTFLOW TRACT MORPHOGENESIS | 4 | 56 | 0.001175 | 0.006799 |
805 | MYELOID LEUKOCYTE DIFFERENTIATION | 5 | 96 | 0.001201 | 0.006934 |
806 | FEMALE GAMETE GENERATION | 5 | 96 | 0.001201 | 0.006934 |
807 | DEVELOPMENTAL PROGRAMMED CELL DEATH | 3 | 26 | 0.001247 | 0.007119 |
808 | REPLACEMENT OSSIFICATION | 3 | 26 | 0.001247 | 0.007119 |
809 | DEFENSE RESPONSE | 21 | 1231 | 0.001242 | 0.007119 |
810 | NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT | 3 | 26 | 0.001247 | 0.007119 |
811 | ENDOCHONDRAL OSSIFICATION | 3 | 26 | 0.001247 | 0.007119 |
812 | PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING | 3 | 26 | 0.001247 | 0.007119 |
813 | MYELOID DENDRITIC CELL ACTIVATION | 3 | 26 | 0.001247 | 0.007119 |
814 | POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 3 | 26 | 0.001247 | 0.007119 |
815 | REGULATION OF CELL FATE COMMITMENT | 3 | 26 | 0.001247 | 0.007119 |
816 | MEMBRANE ORGANIZATION | 17 | 899 | 0.001251 | 0.007134 |
817 | ENDOTHELIAL CELL MIGRATION | 4 | 57 | 0.001256 | 0.007141 |
818 | MYOTUBE DIFFERENTIATION | 4 | 57 | 0.001256 | 0.007141 |
819 | REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 6 | 144 | 0.001257 | 0.007141 |
820 | POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION | 11 | 448 | 0.001265 | 0.007179 |
821 | POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY | 7 | 197 | 0.001268 | 0.007188 |
822 | MEMORY | 5 | 98 | 0.001317 | 0.007446 |
823 | MYELOID LEUKOCYTE ACTIVATION | 5 | 98 | 0.001317 | 0.007446 |
824 | CYTOKINE MEDIATED SIGNALING PATHWAY | 11 | 452 | 0.001358 | 0.007668 |
825 | REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 5 | 99 | 0.001378 | 0.007763 |
826 | REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 5 | 99 | 0.001378 | 0.007763 |
827 | EXCITATORY POSTSYNAPTIC POTENTIAL | 3 | 27 | 0.001394 | 0.007807 |
828 | POSITIVE REGULATION OF NEUTROPHIL MIGRATION | 3 | 27 | 0.001394 | 0.007807 |
829 | POSITIVE REGULATION OF FILOPODIUM ASSEMBLY | 3 | 27 | 0.001394 | 0.007807 |
830 | AXIS ELONGATION | 3 | 27 | 0.001394 | 0.007807 |
831 | REGULATION OF NEUTROPHIL CHEMOTAXIS | 3 | 27 | 0.001394 | 0.007807 |
832 | POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 4 | 59 | 0.001428 | 0.007968 |
833 | VASCULOGENESIS | 4 | 59 | 0.001428 | 0.007968 |
834 | REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 4 | 59 | 0.001428 | 0.007968 |
835 | REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 5 | 100 | 0.001441 | 0.008011 |
836 | POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 5 | 100 | 0.001441 | 0.008011 |
837 | LIMBIC SYSTEM DEVELOPMENT | 5 | 100 | 0.001441 | 0.008011 |
838 | CELLULAR RESPONSE TO LIPID | 11 | 457 | 0.001482 | 0.008227 |
839 | NEURAL TUBE DEVELOPMENT | 6 | 149 | 0.001497 | 0.008302 |
840 | PLASMA MEMBRANE ORGANIZATION | 7 | 203 | 0.001507 | 0.008336 |
841 | REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 5 | 101 | 0.001506 | 0.008336 |
842 | STEM CELL PROLIFERATION | 4 | 60 | 0.001521 | 0.008393 |
843 | REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION | 4 | 60 | 0.001521 | 0.008393 |
844 | POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 3 | 28 | 0.001552 | 0.008527 |
845 | POSITIVE REGULATION OF TELOMERASE ACTIVITY | 3 | 28 | 0.001552 | 0.008527 |
846 | NEGATIVE REGULATION OF DENDRITE DEVELOPMENT | 3 | 28 | 0.001552 | 0.008527 |
847 | REGULATION OF SPROUTING ANGIOGENESIS | 3 | 28 | 0.001552 | 0.008527 |
848 | NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 5 | 102 | 0.001573 | 0.008633 |
849 | CELL PROJECTION ASSEMBLY | 8 | 264 | 0.001602 | 0.008781 |
850 | POSITIVE REGULATION OF CYCLASE ACTIVITY | 4 | 61 | 0.001617 | 0.008851 |
851 | REGULATION OF LEUKOCYTE PROLIFERATION | 7 | 206 | 0.001638 | 0.008958 |
852 | REGULATION OF CHROMATIN ORGANIZATION | 6 | 152 | 0.001657 | 0.009048 |
853 | REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 7 | 207 | 0.001684 | 0.009187 |
854 | CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 11 | 465 | 0.001699 | 0.009245 |
855 | ENDOMEMBRANE SYSTEM ORGANIZATION | 11 | 465 | 0.001699 | 0.009245 |
856 | EPIDERMIS MORPHOGENESIS | 3 | 29 | 0.001721 | 0.009257 |
857 | NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 3 | 29 | 0.001721 | 0.009257 |
858 | REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 3 | 29 | 0.001721 | 0.009257 |
859 | REGULATION OF HEART MORPHOGENESIS | 3 | 29 | 0.001721 | 0.009257 |
860 | RESPONSE TO PAIN | 3 | 29 | 0.001721 | 0.009257 |
861 | MUSCLE ADAPTATION | 3 | 29 | 0.001721 | 0.009257 |
862 | REGULATION OF SMOOTHENED SIGNALING PATHWAY | 4 | 62 | 0.001717 | 0.009257 |
863 | POSITIVE REGULATION OF NUCLEAR DIVISION | 4 | 62 | 0.001717 | 0.009257 |
864 | NEUROBLAST PROLIFERATION | 3 | 29 | 0.001721 | 0.009257 |
865 | CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES | 5 | 104 | 0.001714 | 0.009257 |
866 | LIPID BIOSYNTHETIC PROCESS | 12 | 539 | 0.00176 | 0.009455 |
867 | ODONTOGENESIS | 5 | 105 | 0.001788 | 0.009598 |
868 | TRANSMEMBRANE TRANSPORT | 19 | 1098 | 0.001818 | 0.009745 |
869 | RESPONSE TO OSMOTIC STRESS | 4 | 63 | 0.001822 | 0.009757 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | PROTEIN KINASE ACTIVITY | 66 | 640 | 4.647e-55 | 4.317e-52 |
2 | RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY | 36 | 92 | 5.407e-52 | 2.512e-49 |
3 | PROTEIN SERINE THREONINE KINASE ACTIVITY | 54 | 445 | 3.284e-48 | 1.017e-45 |
4 | KINASE ACTIVITY | 66 | 842 | 2.863e-47 | 6.65e-45 |
5 | RECEPTOR SIGNALING PROTEIN ACTIVITY | 38 | 172 | 6.023e-44 | 1.119e-41 |
6 | TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 66 | 992 | 9.969e-43 | 1.543e-40 |
7 | RIBONUCLEOTIDE BINDING | 75 | 1860 | 3.84e-34 | 5.096e-32 |
8 | ADENYL NUCLEOTIDE BINDING | 65 | 1514 | 1.579e-30 | 1.833e-28 |
9 | KINASE BINDING | 43 | 606 | 3.413e-28 | 3.523e-26 |
10 | ENZYME BINDING | 62 | 1737 | 1.386e-24 | 1.288e-22 |
11 | MAP KINASE KINASE KINASE ACTIVITY | 13 | 22 | 2.366e-22 | 1.998e-20 |
12 | SIGNAL TRANSDUCER ACTIVITY | 57 | 1731 | 1.038e-20 | 8.033e-19 |
13 | VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 14 | 42 | 1.671e-19 | 1.194e-17 |
14 | HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 9 | 11 | 7.703e-18 | 5.112e-16 |
15 | MAP KINASE PHOSPHATASE ACTIVITY | 9 | 14 | 2.745e-16 | 1.7e-14 |
16 | PROTEIN TYROSINE KINASE ACTIVITY | 19 | 176 | 4.116e-16 | 2.39e-14 |
17 | MOLECULAR FUNCTION REGULATOR | 44 | 1353 | 1.45e-15 | 7.924e-14 |
18 | PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 18 | 178 | 8.124e-15 | 4.193e-13 |
19 | RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 19 | 228 | 4.954e-14 | 2.422e-12 |
20 | CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 15 | 128 | 1.732e-13 | 8.044e-12 |
21 | GROWTH FACTOR ACTIVITY | 16 | 160 | 3.214e-13 | 1.422e-11 |
22 | PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 12 | 70 | 4.669e-13 | 1.972e-11 |
23 | MAGNESIUM ION BINDING | 17 | 199 | 7.588e-13 | 3.065e-11 |
24 | GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 20 | 303 | 8.324e-13 | 3.222e-11 |
25 | PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 13 | 103 | 2.866e-12 | 1.065e-10 |
26 | VOLTAGE GATED CATION CHANNEL ACTIVITY | 14 | 134 | 5.631e-12 | 2.012e-10 |
27 | DIVALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 15 | 167 | 8.718e-12 | 2.999e-10 |
28 | PHOSPHATASE ACTIVITY | 18 | 275 | 1.423e-11 | 4.721e-10 |
29 | PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY | 9 | 39 | 2.437e-11 | 7.806e-10 |
30 | FIBROBLAST GROWTH FACTOR RECEPTOR BINDING | 8 | 28 | 4.887e-11 | 1.513e-09 |
31 | GROWTH FACTOR RECEPTOR BINDING | 13 | 129 | 5.243e-11 | 1.522e-09 |
32 | RECEPTOR BINDING | 39 | 1476 | 5.241e-11 | 1.522e-09 |
33 | VOLTAGE GATED ION CHANNEL ACTIVITY | 15 | 190 | 5.561e-11 | 1.566e-09 |
34 | X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 9 | 43 | 6.304e-11 | 1.723e-09 |
35 | PROTEIN TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 9 | 45 | 9.768e-11 | 2.593e-09 |
36 | PHOSPHATIDYLINOSITOL KINASE ACTIVITY | 9 | 51 | 3.215e-10 | 8.296e-09 |
37 | MAP KINASE ACTIVITY | 6 | 14 | 8.183e-10 | 2.055e-08 |
38 | PHOSPHORIC ESTER HYDROLASE ACTIVITY | 18 | 368 | 1.619e-09 | 3.957e-08 |
39 | MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING | 6 | 18 | 4.922e-09 | 1.173e-07 |
40 | GROWTH FACTOR BINDING | 11 | 123 | 5.99e-09 | 1.391e-07 |
41 | PROTEIN DIMERIZATION ACTIVITY | 30 | 1149 | 1.736e-08 | 3.933e-07 |
42 | TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 9 | 81 | 2.232e-08 | 4.937e-07 |
43 | CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY | 5 | 12 | 2.718e-08 | 5.627e-07 |
44 | MAP KINASE KINASE ACTIVITY | 5 | 12 | 2.718e-08 | 5.627e-07 |
45 | CATION CHANNEL ACTIVITY | 15 | 298 | 2.726e-08 | 5.627e-07 |
46 | GATED CHANNEL ACTIVITY | 15 | 325 | 8.52e-08 | 1.721e-06 |
47 | KINASE ACTIVATOR ACTIVITY | 7 | 62 | 7.691e-07 | 1.52e-05 |
48 | HYDROLASE ACTIVITY ACTING ON ESTER BONDS | 21 | 739 | 8.028e-07 | 1.554e-05 |
49 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 7 | 64 | 9.581e-07 | 1.817e-05 |
50 | DIACYLGLYCEROL BINDING | 4 | 11 | 1.409e-06 | 2.618e-05 |
51 | PROTEIN HETERODIMERIZATION ACTIVITY | 16 | 468 | 1.746e-06 | 3.18e-05 |
52 | METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 15 | 417 | 2.006e-06 | 3.585e-05 |
53 | UBIQUITIN LIKE PROTEIN LIGASE BINDING | 12 | 264 | 2.059e-06 | 3.609e-05 |
54 | IDENTICAL PROTEIN BINDING | 27 | 1209 | 2.117e-06 | 3.642e-05 |
55 | HISTONE DEACETYLASE BINDING | 8 | 105 | 2.56e-06 | 4.325e-05 |
56 | CYTOKINE RECEPTOR BINDING | 12 | 271 | 2.7e-06 | 4.479e-05 |
57 | KINASE REGULATOR ACTIVITY | 10 | 186 | 3.414e-06 | 5.565e-05 |
58 | ENZYME REGULATOR ACTIVITY | 23 | 959 | 4.136e-06 | 6.624e-05 |
59 | PROTEIN DOMAIN SPECIFIC BINDING | 18 | 624 | 4.234e-06 | 6.666e-05 |
60 | HEPARIN BINDING | 9 | 157 | 6.344e-06 | 9.822e-05 |
61 | PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 15 | 464 | 7.32e-06 | 0.0001115 |
62 | MITOGEN ACTIVATED PROTEIN KINASE KINASE BINDING | 4 | 16 | 7.524e-06 | 0.0001127 |
63 | GLYCOSAMINOGLYCAN BINDING | 10 | 205 | 8.084e-06 | 0.0001192 |
64 | ENZYME ACTIVATOR ACTIVITY | 15 | 471 | 8.749e-06 | 0.000127 |
65 | MACROMOLECULAR COMPLEX BINDING | 28 | 1399 | 1.074e-05 | 0.0001534 |
66 | PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 4 | 19 | 1.572e-05 | 0.0002179 |
67 | HISTONE KINASE ACTIVITY | 4 | 19 | 1.572e-05 | 0.0002179 |
68 | SMAD BINDING | 6 | 72 | 2.868e-05 | 0.0003918 |
69 | PROTEIN HOMODIMERIZATION ACTIVITY | 18 | 722 | 3.019e-05 | 0.0004037 |
70 | TRANSCRIPTION FACTOR BINDING | 15 | 524 | 3.042e-05 | 0.0004037 |
71 | INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 15 | 527 | 3.248e-05 | 0.0004249 |
72 | SCAFFOLD PROTEIN BINDING | 5 | 45 | 3.365e-05 | 0.0004342 |
73 | TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 5 | 50 | 5.645e-05 | 0.0007184 |
74 | PROTEIN COMPLEX BINDING | 20 | 935 | 9.156e-05 | 0.001149 |
75 | CHANNEL REGULATOR ACTIVITY | 7 | 131 | 0.0001085 | 0.001344 |
76 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 9 | 226 | 0.0001116 | 0.001364 |
77 | PHOSPHOPROTEIN BINDING | 5 | 60 | 0.0001362 | 0.001643 |
78 | SULFUR COMPOUND BINDING | 9 | 234 | 0.0001452 | 0.001729 |
79 | PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 5 | 64 | 0.0001851 | 0.002177 |
80 | NEUROTROPHIN RECEPTOR BINDING | 3 | 14 | 0.0001877 | 0.00218 |
81 | CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 15 | 622 | 0.0002049 | 0.00235 |
82 | GTPASE ACTIVITY | 9 | 246 | 0.000211 | 0.00239 |
83 | PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING | 3 | 15 | 0.0002332 | 0.002611 |
84 | TRANSFORMING GROWTH FACTOR BETA BINDING | 3 | 16 | 0.0002853 | 0.003118 |
85 | PROTEIN KINASE C ACTIVITY | 3 | 16 | 0.0002853 | 0.003118 |
86 | GTP DEPENDENT PROTEIN BINDING | 3 | 17 | 0.0003444 | 0.00372 |
87 | CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 4 | 42 | 0.0003916 | 0.004181 |
88 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 10 | 328 | 0.0004073 | 0.004252 |
89 | GUANYL NUCLEOTIDE BINDING | 11 | 390 | 0.0004064 | 0.004252 |
90 | ADRENERGIC RECEPTOR BINDING | 3 | 19 | 0.0004848 | 0.005004 |
91 | CALMODULIN BINDING | 7 | 179 | 0.0007254 | 0.007406 |
92 | R SMAD BINDING | 3 | 23 | 0.0008649 | 0.008548 |
93 | FIBROBLAST GROWTH FACTOR BINDING | 3 | 23 | 0.0008649 | 0.008548 |
94 | CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 3 | 23 | 0.0008649 | 0.008548 |
95 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING | 5 | 90 | 0.0008985 | 0.008787 |
96 | MITOGEN ACTIVATED PROTEIN KINASE BINDING | 3 | 24 | 0.0009825 | 0.00941 |
97 | PROTEIN PHOSPHORYLATED AMINO ACID BINDING | 3 | 24 | 0.0009825 | 0.00941 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | VOLTAGE GATED CALCIUM CHANNEL COMPLEX | 16 | 40 | 1.16e-23 | 6.776e-21 |
2 | CALCIUM CHANNEL COMPLEX | 17 | 62 | 8.788e-22 | 2.566e-19 |
3 | CATION CHANNEL COMPLEX | 17 | 167 | 4.199e-14 | 8.175e-12 |
4 | PLASMA MEMBRANE PROTEIN COMPLEX | 26 | 510 | 1.035e-13 | 1.511e-11 |
5 | SARCOLEMMA | 12 | 125 | 5.234e-10 | 6.114e-08 |
6 | TRANSPORTER COMPLEX | 17 | 321 | 1.427e-09 | 1.389e-07 |
7 | PROTEIN KINASE COMPLEX | 10 | 90 | 3.602e-09 | 3.005e-07 |
8 | MEMBRANE PROTEIN COMPLEX | 29 | 1020 | 4.768e-09 | 3.481e-07 |
9 | CELL SUBSTRATE JUNCTION | 18 | 398 | 5.545e-09 | 3.598e-07 |
10 | IKAPPAB KINASE COMPLEX | 5 | 11 | 1.596e-08 | 9.323e-07 |
11 | T TUBULE | 7 | 45 | 7.982e-08 | 4.238e-06 |
12 | SOMATODENDRITIC COMPARTMENT | 21 | 650 | 9.756e-08 | 4.748e-06 |
13 | ANCHORING JUNCTION | 18 | 489 | 1.277e-07 | 5.736e-06 |
14 | NEURON PROJECTION | 25 | 942 | 2.337e-07 | 9.747e-06 |
15 | PERINUCLEAR REGION OF CYTOPLASM | 20 | 642 | 3.598e-07 | 1.401e-05 |
16 | NEURON PART | 29 | 1265 | 4.892e-07 | 1.786e-05 |
17 | CYTOPLASMIC SIDE OF MEMBRANE | 10 | 170 | 1.519e-06 | 5.217e-05 |
18 | SIDE OF MEMBRANE | 15 | 428 | 2.761e-06 | 8.957e-05 |
19 | SYNAPSE | 20 | 754 | 4.251e-06 | 0.0001307 |
20 | EXCITATORY SYNAPSE | 10 | 197 | 5.692e-06 | 0.0001662 |
21 | CELL JUNCTION | 25 | 1151 | 8.585e-06 | 0.0002279 |
22 | CELL PROJECTION | 33 | 1786 | 8.343e-06 | 0.0002279 |
23 | CELL BODY | 15 | 494 | 1.535e-05 | 0.0003899 |
24 | DENDRITE | 14 | 451 | 2.341e-05 | 0.0005697 |
25 | TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 10 | 237 | 2.838e-05 | 0.0006629 |
26 | I BAND | 7 | 121 | 6.573e-05 | 0.001476 |
27 | CD40 RECEPTOR COMPLEX | 3 | 11 | 8.666e-05 | 0.001851 |
28 | RECEPTOR COMPLEX | 11 | 327 | 8.875e-05 | 0.001851 |
29 | MEMBRANE MICRODOMAIN | 10 | 288 | 0.0001441 | 0.002902 |
30 | SYNAPSE PART | 15 | 610 | 0.0001661 | 0.003233 |
31 | INTRACELLULAR VESICLE | 23 | 1259 | 0.0002767 | 0.005154 |
32 | ACTIN FILAMENT | 5 | 70 | 0.0002824 | 0.005154 |
33 | POSTSYNAPSE | 11 | 378 | 0.0003122 | 0.005525 |
34 | PSEUDOPODIUM | 3 | 17 | 0.0003444 | 0.005915 |
35 | EXTRACELLULAR SPACE | 24 | 1376 | 0.0003974 | 0.00663 |
36 | MEMBRANE REGION | 21 | 1134 | 0.0004353 | 0.007061 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | hsa04010_MAPK_signaling_pathway | 165 | 268 | 0 | 0 | |
2 | hsa04014_Ras_signaling_pathway | 61 | 236 | 2.232e-76 | 2.009e-74 | |
3 | hsa04722_Neurotrophin_signaling_pathway | 35 | 127 | 3.282e-44 | 1.969e-42 | |
4 | hsa04912_GnRH_signaling_pathway | 30 | 101 | 5.028e-39 | 2.262e-37 | |
5 | hsa04380_Osteoclast_differentiation | 31 | 128 | 3.355e-37 | 1.208e-35 | |
6 | hsa04810_Regulation_of_actin_cytoskeleton | 34 | 214 | 4.391e-34 | 1.175e-32 | |
7 | hsa04662_B_cell_receptor_signaling_pathway | 25 | 75 | 4.57e-34 | 1.175e-32 | |
8 | hsa04664_Fc_epsilon_RI_signaling_pathway | 25 | 79 | 2.113e-33 | 4.754e-32 | |
9 | hsa04151_PI3K_AKT_signaling_pathway | 39 | 351 | 6.277e-33 | 1.255e-31 | |
10 | hsa04660_T_cell_receptor_signaling_pathway | 27 | 108 | 7.253e-33 | 1.306e-31 | |
11 | hsa04370_VEGF_signaling_pathway | 23 | 76 | 2.884e-30 | 4.72e-29 | |
12 | hsa04620_Toll.like_receptor_signaling_pathway | 24 | 102 | 1.389e-28 | 2.084e-27 | |
13 | hsa04012_ErbB_signaling_pathway | 22 | 87 | 4.935e-27 | 6.833e-26 | |
14 | hsa04720_Long.term_potentiation | 20 | 70 | 7.424e-26 | 9.545e-25 | |
15 | hsa04510_Focal_adhesion | 26 | 200 | 8.038e-24 | 9.646e-23 | |
16 | hsa04062_Chemokine_signaling_pathway | 25 | 189 | 4.004e-23 | 4.505e-22 | |
17 | hsa04210_Apoptosis | 19 | 89 | 6.175e-22 | 6.538e-21 | |
18 | hsa04914_Progesterone.mediated_oocyte_maturation | 18 | 87 | 1.433e-20 | 1.433e-19 | |
19 | hsa04540_Gap_junction | 18 | 90 | 2.763e-20 | 2.618e-19 | |
20 | hsa04310_Wnt_signaling_pathway | 21 | 151 | 5.002e-20 | 4.502e-19 | |
21 | hsa04650_Natural_killer_cell_mediated_cytotoxicity | 20 | 136 | 1.285e-19 | 1.101e-18 | |
22 | hsa04910_Insulin_signaling_pathway | 19 | 138 | 3.949e-18 | 3.231e-17 | |
23 | hsa04020_Calcium_signaling_pathway | 19 | 177 | 4.578e-16 | 3.583e-15 | |
24 | hsa04730_Long.term_depression | 13 | 70 | 1.606e-14 | 1.205e-13 | |
25 | hsa04270_Vascular_smooth_muscle_contraction | 15 | 116 | 3.926e-14 | 2.827e-13 | |
26 | hsa04621_NOD.like_receptor_signaling_pathway | 12 | 59 | 5.312e-14 | 3.677e-13 | |
27 | hsa04144_Endocytosis | 16 | 203 | 1.266e-11 | 8.439e-11 | |
28 | hsa04360_Axon_guidance | 13 | 130 | 5.784e-11 | 3.718e-10 | |
29 | hsa04114_Oocyte_meiosis | 12 | 114 | 1.774e-10 | 1.101e-09 | |
30 | hsa04622_RIG.I.like_receptor_signaling_pathway | 10 | 71 | 3.325e-10 | 1.995e-09 | |
31 | hsa04666_Fc_gamma_R.mediated_phagocytosis | 11 | 95 | 3.701e-10 | 2.149e-09 | |
32 | hsa04520_Adherens_junction | 10 | 73 | 4.412e-10 | 2.482e-09 | |
33 | hsa04916_Melanogenesis | 11 | 101 | 7.22e-10 | 3.938e-09 | |
34 | hsa04260_Cardiac_muscle_contraction | 10 | 77 | 7.572e-10 | 4.009e-09 | |
35 | hsa04920_Adipocytokine_signaling_pathway | 9 | 68 | 4.62e-09 | 2.376e-08 | |
36 | hsa04320_Dorso.ventral_axis_formation | 6 | 25 | 4.477e-08 | 2.238e-07 | |
37 | hsa04530_Tight_junction | 10 | 133 | 1.568e-07 | 7.629e-07 | |
38 | hsa04150_mTOR_signaling_pathway | 7 | 52 | 2.242e-07 | 1.062e-06 | |
39 | hsa04972_Pancreatic_secretion | 8 | 101 | 1.908e-06 | 8.807e-06 | |
40 | hsa04350_TGF.beta_signaling_pathway | 7 | 85 | 6.585e-06 | 2.963e-05 | |
41 | hsa04141_Protein_processing_in_endoplasmic_reticulum | 9 | 168 | 1.097e-05 | 4.793e-05 | |
42 | hsa04110_Cell_cycle | 8 | 128 | 1.118e-05 | 4.793e-05 | |
43 | hsa04960_Aldosterone.regulated_sodium_reabsorption | 5 | 42 | 2.39e-05 | 0.0001001 | |
44 | hsa04971_Gastric_acid_secretion | 6 | 74 | 3.354e-05 | 0.0001372 | |
45 | hsa04390_Hippo_signaling_pathway | 8 | 154 | 4.258e-05 | 0.0001703 | |
46 | hsa04670_Leukocyte_transendothelial_migration | 7 | 117 | 5.307e-05 | 0.0002077 | |
47 | hsa04742_Taste_transduction | 5 | 52 | 6.833e-05 | 0.0002617 | |
48 | hsa04970_Salivary_secretion | 6 | 89 | 9.504e-05 | 0.0003564 | |
49 | hsa04623_Cytosolic_DNA.sensing_pathway | 5 | 56 | 9.78e-05 | 0.0003593 | |
50 | hsa04973_Carbohydrate_digestion_and_absorption | 4 | 44 | 0.0004689 | 0.001688 | |
51 | hsa00592_alpha.Linolenic_acid_metabolism | 3 | 20 | 0.0005669 | 0.002001 | |
52 | hsa00591_Linoleic_acid_metabolism | 3 | 30 | 0.001901 | 0.006579 | |
53 | hsa04115_p53_signaling_pathway | 4 | 69 | 0.002546 | 0.008645 | |
54 | hsa00565_Ether_lipid_metabolism | 3 | 36 | 0.003224 | 0.01075 | |
55 | hsa04612_Antigen_processing_and_presentation | 4 | 78 | 0.003967 | 0.01298 | |
56 | hsa04962_Vasopressin.regulated_water_reabsorption | 3 | 44 | 0.005699 | 0.01832 | |
57 | hsa04640_Hematopoietic_cell_lineage | 4 | 88 | 0.006086 | 0.01922 | |
58 | hsa04975_Fat_digestion_and_absorption | 3 | 46 | 0.006454 | 0.02003 | |
59 | hsa04630_Jak.STAT_signaling_pathway | 5 | 155 | 0.009324 | 0.02845 | |
60 | hsa04340_Hedgehog_signaling_pathway | 3 | 56 | 0.0111 | 0.03331 | |
61 | hsa00590_Arachidonic_acid_metabolism | 3 | 59 | 0.01279 | 0.03774 | |
62 | hsa04976_Bile_secretion | 3 | 71 | 0.02093 | 0.06078 | |
63 | hsa03040_Spliceosome | 4 | 128 | 0.02165 | 0.06185 | |
64 | hsa04744_Phototransduction | 2 | 29 | 0.02374 | 0.06677 | |
65 | hsa04070_Phosphatidylinositol_signaling_system | 3 | 78 | 0.02673 | 0.07403 | |
66 | hsa00564_Glycerophospholipid_metabolism | 3 | 80 | 0.02853 | 0.07781 | |
67 | hsa04672_Intestinal_immune_network_for_IgA_production | 2 | 49 | 0.06183 | 0.1661 | |
68 | hsa04145_Phagosome | 2 | 156 | 0.3694 | 0.9778 | |
69 | hsa04740_Olfactory_transduction | 4 | 388 | 0.3983 | 1 |
Num | lncRNA | miRNAs | miRNAs count | Gene | Sponge regulatory network | lncRNA log2FC | lncRNA pvalue | Gene log2FC | Gene pvalue | lncRNA-gene Pearson correlation |
---|---|---|---|---|---|---|---|---|---|---|
1 | PCA3 |
hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-16-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-182-5p;hsa-miR-200c-5p;hsa-miR-23a-3p;hsa-miR-27a-3p;hsa-miR-32-3p;hsa-miR-369-3p;hsa-miR-370-3p;hsa-miR-590-3p;hsa-miR-654-5p;hsa-miR-93-3p;hsa-miR-96-5p | 18 | CACNB2 | Sponge network | -2.778 | 8.0E-5 | -2.086 | 1.0E-5 | 0.684 |
2 | PCA3 |
hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-1254;hsa-miR-1271-5p;hsa-miR-148b-5p;hsa-miR-149-5p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-320b;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-589-3p;hsa-miR-93-3p;hsa-miR-944;hsa-miR-96-5p | 21 | CACNA1C | Sponge network | -2.778 | 8.0E-5 | -1.469 | 0.0005 | 0.509 |
3 | PCA3 |
hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-20a-5p;hsa-miR-27a-3p;hsa-miR-320b;hsa-miR-33a-3p;hsa-miR-3662;hsa-miR-424-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-616-5p;hsa-miR-944 | 20 | FGF7 | Sponge network | -2.778 | 8.0E-5 | -1.56 | 0.00499 | 0.493 |
4 | MEG3 |
hsa-miR-107;hsa-miR-1254;hsa-miR-1976;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-320b;hsa-miR-378a-5p;hsa-miR-429;hsa-miR-577;hsa-miR-7-1-3p;hsa-miR-93-3p;hsa-miR-96-5p | 15 | CACNA1C | Sponge network | -1.645 | 0.00049 | -1.469 | 0.0005 | 0.469 |
5 | RFPL1S |
hsa-miR-106b-5p;hsa-miR-107;hsa-miR-17-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-320b;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-501-3p;hsa-miR-502-3p;hsa-miR-505-3p | 11 | AKT3 | Sponge network | -0.223 | 0.70704 | -0.749 | 0.06936 | 0.466 |
6 | MEG3 |
hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-20a-5p;hsa-miR-31-5p;hsa-miR-320b;hsa-miR-33a-3p;hsa-miR-3662;hsa-miR-429;hsa-miR-577;hsa-miR-616-5p;hsa-miR-7-1-3p | 16 | FGF7 | Sponge network | -1.645 | 0.00049 | -1.56 | 0.00499 | 0.458 |
7 | MEG3 |
hsa-miR-130b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-652-3p;hsa-miR-7-1-3p;hsa-miR-96-5p | 11 | MRAS | Sponge network | -1.645 | 0.00049 | -0.939 | 0.01023 | 0.445 |
8 | CASC2 |
hsa-miR-183-5p;hsa-miR-193b-3p;hsa-miR-193b-5p;hsa-miR-218-5p;hsa-miR-22-5p;hsa-miR-224-5p;hsa-miR-2355-3p;hsa-miR-24-2-5p;hsa-miR-369-3p;hsa-miR-452-5p;hsa-miR-654-3p;hsa-miR-944 | 12 | PRKCA | Sponge network | -0.561 | 0.05962 | -0.525 | 0.15685 | 0.436 |
9 | PLAC4 |
hsa-miR-127-5p;hsa-miR-149-5p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-331-3p;hsa-miR-511-5p;hsa-miR-582-3p;hsa-miR-940;hsa-miR-944 | 12 | RAPGEF2 | Sponge network | -0.563 | 0.27163 | -0.748 | 0.00078 | 0.432 |
10 | CASC2 |
hsa-miR-127-5p;hsa-miR-149-5p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-331-3p;hsa-miR-369-3p;hsa-miR-511-5p;hsa-miR-940;hsa-miR-944 | 12 | RAPGEF2 | Sponge network | -0.561 | 0.05962 | -0.748 | 0.00078 | 0.417 |
11 | PCA3 |
hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7f-1-3p;hsa-miR-103a-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-21-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-330-3p;hsa-miR-335-5p;hsa-miR-3662;hsa-miR-3682-3p;hsa-miR-424-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-3p | 28 | FGF2 | Sponge network | -2.778 | 8.0E-5 | -1.879 | 0.00013 | 0.416 |
12 | MEG3 |
hsa-miR-103a-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-330-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-3662;hsa-miR-429;hsa-miR-577;hsa-miR-93-3p | 19 | FGF2 | Sponge network | -1.645 | 0.00049 | -1.879 | 0.00013 | 0.415 |
13 | MEG3 |
hsa-miR-106b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-330-3p;hsa-miR-335-3p;hsa-miR-577 | 11 | FGFR1 | Sponge network | -1.645 | 0.00049 | -1.499 | 0.00051 | 0.412 |
14 | MEG3 |
hsa-miR-106b-5p;hsa-miR-107;hsa-miR-1254;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-330-3p;hsa-miR-331-3p;hsa-miR-429;hsa-miR-7-1-3p;hsa-miR-93-5p;hsa-miR-96-5p | 16 | MAP3K3 | Sponge network | -1.645 | 0.00049 | -0.635 | 0.00017 | 0.409 |
15 | PCA3 |
hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-1296-5p;hsa-miR-130b-5p;hsa-miR-135b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200c-5p;hsa-miR-224-3p;hsa-miR-23a-3p;hsa-miR-27a-3p;hsa-miR-32-3p;hsa-miR-320b;hsa-miR-324-3p;hsa-miR-331-5p;hsa-miR-33a-3p;hsa-miR-33b-5p;hsa-miR-3613-5p;hsa-miR-425-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-744-3p;hsa-miR-940;hsa-miR-96-5p | 31 | MEF2C | Sponge network | -2.778 | 8.0E-5 | -0.552 | 0.096 | 0.403 |
16 | MALAT1 |
hsa-miR-106b-5p;hsa-miR-149-5p;hsa-miR-15b-5p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-331-3p;hsa-miR-379-5p | 10 | RAPGEF2 | Sponge network | -1.099 | 0.0005 | -0.748 | 0.00078 | 0.398 |
17 | KCNQ1OT1 |
hsa-let-7a-2-3p;hsa-let-7b-5p;hsa-miR-152-3p;hsa-miR-199a-3p;hsa-miR-199b-3p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-28-5p | 11 | NLK | Sponge network | -0.725 | 0.08874 | 0.087 | 0.60941 | 0.392 |
18 | MEG3 |
hsa-miR-130b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200c-5p;hsa-miR-320b;hsa-miR-324-3p;hsa-miR-331-5p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-550a-3p;hsa-miR-744-3p;hsa-miR-96-5p | 17 | MEF2C | Sponge network | -1.645 | 0.00049 | -0.552 | 0.096 | 0.39 |
19 | PCA3 |
hsa-miR-141-5p;hsa-miR-16-2-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-452-3p;hsa-miR-589-3p;hsa-miR-589-5p;hsa-miR-590-5p;hsa-miR-616-5p | 12 | PRKCB | Sponge network | -2.778 | 8.0E-5 | -1.403 | 0.00367 | 0.387 |
20 | PCA3 |
hsa-miR-106b-5p;hsa-miR-107;hsa-miR-1254;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-182-5p;hsa-miR-185-3p;hsa-miR-188-5p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-221-5p;hsa-miR-330-3p;hsa-miR-331-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-424-5p;hsa-miR-93-5p;hsa-miR-96-5p | 23 | MAP3K3 | Sponge network | -2.778 | 8.0E-5 | -0.635 | 0.00017 | 0.384 |
21 | DGCR5 |
hsa-miR-107;hsa-miR-140-3p;hsa-miR-148a-5p;hsa-miR-30d-3p;hsa-miR-30d-5p;hsa-miR-326;hsa-miR-338-3p;hsa-miR-362-5p;hsa-miR-501-5p;hsa-miR-577 | 10 | NTRK2 | Sponge network | 1.383 | 0.01835 | 0.129 | 0.90432 | 0.38 |
22 | MEG3 |
hsa-let-7g-3p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-196a-5p;hsa-miR-196b-5p;hsa-miR-20a-5p;hsa-miR-219a-5p;hsa-miR-335-3p;hsa-miR-93-5p;hsa-miR-96-5p | 14 | PDGFRA | Sponge network | -1.645 | 0.00049 | -1.161 | 0.00469 | 0.38 |
23 | PLAC4 |
hsa-miR-127-5p;hsa-miR-1271-5p;hsa-miR-149-5p;hsa-miR-183-5p;hsa-miR-205-5p;hsa-miR-224-3p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-34c-3p;hsa-miR-708-5p;hsa-miR-940;hsa-miR-944 | 15 | MAP3K13 | Sponge network | -0.563 | 0.27163 | 0.158 | 0.68798 | 0.377 |
24 | FAM66C | hsa-let-7b-3p;hsa-let-7f-1-3p;hsa-miR-135b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-27a-3p;hsa-miR-3613-5p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p | 12 | MEF2C | Sponge network | -0.353 | 0.40349 | -0.552 | 0.096 | 0.375 |
25 | KCNQ1OT1 |
hsa-miR-125b-5p;hsa-miR-127-5p;hsa-miR-1271-5p;hsa-miR-149-5p;hsa-miR-183-5p;hsa-miR-205-5p;hsa-miR-224-3p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-34c-3p;hsa-miR-708-5p;hsa-miR-944 | 15 | MAP3K13 | Sponge network | -0.725 | 0.08874 | 0.158 | 0.68798 | 0.366 |
26 | EMX2OS |
hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-192-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-21-3p;hsa-miR-215-5p;hsa-miR-222-3p;hsa-miR-29a-5p;hsa-miR-335-3p;hsa-miR-424-5p;hsa-miR-503-5p;hsa-miR-577;hsa-miR-589-3p;hsa-miR-92a-3p;hsa-miR-93-3p | 22 | FGF2 | Sponge network | -1.088 | 0.10042 | -1.879 | 0.00013 | 0.362 |
27 | MEG3 |
hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-200c-5p;hsa-miR-31-5p;hsa-miR-339-5p;hsa-miR-429;hsa-miR-550a-3p;hsa-miR-7-1-3p;hsa-miR-93-3p;hsa-miR-96-5p | 10 | CACNB2 | Sponge network | -1.645 | 0.00049 | -2.086 | 1.0E-5 | 0.357 |
28 | RFPL1S |
hsa-miR-148b-5p;hsa-miR-17-3p;hsa-miR-18a-3p;hsa-miR-29a-5p;hsa-miR-320b;hsa-miR-335-5p;hsa-miR-34a-5p;hsa-miR-362-3p;hsa-miR-429;hsa-miR-7-1-3p | 10 | MAPT | Sponge network | -0.223 | 0.70704 | -2.812 | 0 | 0.357 |
29 | EMX2OS |
hsa-miR-107;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-362-3p;hsa-miR-501-3p;hsa-miR-502-3p;hsa-miR-505-3p;hsa-miR-577 | 12 | AKT3 | Sponge network | -1.088 | 0.10042 | -0.749 | 0.06936 | 0.354 |
30 | CASC2 |
hsa-let-7b-5p;hsa-miR-152-3p;hsa-miR-199a-3p;hsa-miR-199b-3p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-342-3p | 10 | NLK | Sponge network | -0.561 | 0.05962 | 0.087 | 0.60941 | 0.352 |
31 | CASC2 |
hsa-miR-125b-5p;hsa-miR-127-5p;hsa-miR-1271-5p;hsa-miR-149-5p;hsa-miR-183-5p;hsa-miR-205-5p;hsa-miR-224-3p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-369-3p;hsa-miR-708-5p;hsa-miR-940;hsa-miR-944 | 16 | MAP3K13 | Sponge network | -0.561 | 0.05962 | 0.158 | 0.68798 | 0.349 |
32 | EMX2OS |
hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-20a-5p;hsa-miR-424-5p;hsa-miR-577;hsa-miR-7-1-3p | 10 | FGF7 | Sponge network | -1.088 | 0.10042 | -1.56 | 0.00499 | 0.338 |
33 | AGAP11 |
hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-5p;hsa-miR-320b;hsa-miR-335-3p;hsa-miR-421;hsa-miR-424-5p;hsa-miR-590-5p | 12 | PPM1A | Sponge network | -1.728 | 0.00016 | -0.485 | 0.00196 | 0.335 |
34 | AGAP11 |
hsa-miR-16-1-3p;hsa-miR-18a-5p;hsa-miR-222-5p;hsa-miR-26b-3p;hsa-miR-29a-5p;hsa-miR-320b;hsa-miR-326;hsa-miR-532-3p;hsa-miR-590-5p;hsa-miR-629-5p | 10 | FGF1 | Sponge network | -1.728 | 0.00016 | -0.16 | 0.73397 | 0.329 |
35 | RFPL1S |
hsa-miR-107;hsa-miR-192-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-3p;hsa-miR-215-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-5p;hsa-miR-335-5p;hsa-miR-429 | 12 | FGF2 | Sponge network | -0.223 | 0.70704 | -1.879 | 0.00013 | 0.314 |
36 | MEG3 |
hsa-miR-106b-5p;hsa-miR-107;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-320b;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-577;hsa-miR-616-5p | 11 | AKT3 | Sponge network | -1.645 | 0.00049 | -0.749 | 0.06936 | 0.312 |
37 | PCA3 |
hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-149-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-196a-5p;hsa-miR-196b-5p;hsa-miR-20a-5p;hsa-miR-219a-5p;hsa-miR-224-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-590-5p;hsa-miR-93-5p;hsa-miR-944;hsa-miR-96-5p | 26 | PDGFRA | Sponge network | -2.778 | 8.0E-5 | -1.161 | 0.00469 | 0.31 |
38 | EMX2OS |
hsa-miR-107;hsa-miR-1254;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-33b-5p;hsa-miR-378a-5p;hsa-miR-577;hsa-miR-589-3p;hsa-miR-7-1-3p;hsa-miR-877-5p;hsa-miR-93-3p | 13 | CACNA1C | Sponge network | -1.088 | 0.10042 | -1.469 | 0.0005 | 0.306 |
39 | EMX2OS |
hsa-miR-130b-5p;hsa-miR-135b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-200c-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-33b-5p;hsa-miR-425-5p;hsa-miR-550a-3p;hsa-miR-92a-3p | 14 | MEF2C | Sponge network | -1.088 | 0.10042 | -0.552 | 0.096 | 0.304 |
40 | PLAC4 |
hsa-let-7a-2-3p;hsa-let-7b-5p;hsa-miR-152-3p;hsa-miR-199a-3p;hsa-miR-199b-3p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-28-5p | 11 | NLK | Sponge network | -0.563 | 0.27163 | 0.087 | 0.60941 | 0.302 |
41 | RFPL1S |
hsa-miR-126-5p;hsa-miR-18a-5p;hsa-miR-222-5p;hsa-miR-26b-3p;hsa-miR-29a-5p;hsa-miR-320b;hsa-miR-330-5p;hsa-miR-429;hsa-miR-532-3p;hsa-miR-550a-5p;hsa-miR-625-5p;hsa-miR-7-5p | 12 | FGF1 | Sponge network | -0.223 | 0.70704 | -0.16 | 0.73397 | 0.3 |
42 | HCG18 |
hsa-miR-127-5p;hsa-miR-149-5p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-331-3p;hsa-miR-379-5p;hsa-miR-511-5p | 10 | RAPGEF2 | Sponge network | -0.24 | 0.23472 | -0.748 | 0.00078 | 0.288 |
43 | HCG18 |
hsa-let-7a-2-3p;hsa-let-7b-5p;hsa-miR-152-3p;hsa-miR-199a-3p;hsa-miR-199b-3p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-28-5p | 11 | NLK | Sponge network | -0.24 | 0.23472 | 0.087 | 0.60941 | 0.285 |
44 | PCA3 |
hsa-miR-106b-5p;hsa-miR-130a-3p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-301a-3p;hsa-miR-320b;hsa-miR-33a-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p | 14 | TGFBR2 | Sponge network | -2.778 | 8.0E-5 | -1.331 | 0.00013 | 0.283 |
45 | EMX2OS |
hsa-miR-135b-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-335-3p;hsa-miR-577 | 10 | FGFR1 | Sponge network | -1.088 | 0.10042 | -1.499 | 0.00051 | 0.281 |
46 | NEAT1 |
hsa-miR-125b-5p;hsa-miR-127-5p;hsa-miR-1271-5p;hsa-miR-149-5p;hsa-miR-183-5p;hsa-miR-224-3p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-34c-3p;hsa-miR-708-5p;hsa-miR-940 | 11 | MAP3K13 | Sponge network | -0.686 | 0.02293 | 0.158 | 0.68798 | 0.281 |
47 | MALAT1 |
hsa-miR-1296-5p;hsa-miR-183-5p;hsa-miR-224-3p;hsa-miR-23a-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-324-3p;hsa-miR-331-5p;hsa-miR-33b-5p;hsa-miR-452-5p;hsa-miR-744-3p | 11 | MEF2C | Sponge network | -1.099 | 0.0005 | -0.552 | 0.096 | 0.28 |
48 | PCA3 |
hsa-miR-103a-2-5p;hsa-miR-1271-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-193b-5p;hsa-miR-197-3p;hsa-miR-221-3p;hsa-miR-320b;hsa-miR-424-5p;hsa-miR-590-3p | 15 | DUSP3 | Sponge network | -2.778 | 8.0E-5 | -0.882 | 0 | 0.279 |
49 | EMX2OS |
hsa-miR-107;hsa-miR-1254;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-185-3p;hsa-miR-188-5p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-331-3p;hsa-miR-33b-5p;hsa-miR-424-5p;hsa-miR-505-3p;hsa-miR-7-1-3p | 17 | MAP3K3 | Sponge network | -1.088 | 0.10042 | -0.635 | 0.00017 | 0.279 |
50 | PCA3 |
hsa-miR-183-5p;hsa-miR-193b-3p;hsa-miR-193b-5p;hsa-miR-200c-3p;hsa-miR-22-5p;hsa-miR-224-5p;hsa-miR-2355-3p;hsa-miR-369-3p;hsa-miR-590-3p;hsa-miR-93-3p;hsa-miR-944 | 11 | PRKCA | Sponge network | -2.778 | 8.0E-5 | -0.525 | 0.15685 | 0.278 |
51 | MALAT1 |
hsa-miR-1271-5p;hsa-miR-149-5p;hsa-miR-183-5p;hsa-miR-224-3p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-34c-3p | 10 | MAP3K13 | Sponge network | -1.099 | 0.0005 | 0.158 | 0.68798 | 0.276 |
52 | PCA3 |
hsa-miR-106b-5p;hsa-miR-127-5p;hsa-miR-149-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-331-3p;hsa-miR-369-3p;hsa-miR-940;hsa-miR-944 | 12 | RAPGEF2 | Sponge network | -2.778 | 8.0E-5 | -0.748 | 0.00078 | 0.274 |
53 | HAR1A | hsa-miR-103a-2-5p;hsa-miR-130b-5p;hsa-miR-135b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-224-3p;hsa-miR-27a-3p;hsa-miR-324-3p;hsa-miR-744-3p;hsa-miR-940 | 12 | MEF2C | Sponge network | -0.801 | 0.17598 | -0.552 | 0.096 | 0.272 |
54 | EMX2OS |
hsa-let-7d-5p;hsa-miR-107;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-183-5p;hsa-miR-196a-5p;hsa-miR-196b-5p;hsa-miR-20a-3p;hsa-miR-335-3p;hsa-miR-550a-3p;hsa-miR-92a-3p | 11 | CACNB4 | Sponge network | -1.088 | 0.10042 | -2.124 | 0.00021 | 0.266 |
55 | AGAP11 |
hsa-miR-106b-5p;hsa-miR-107;hsa-miR-128-3p;hsa-miR-1292-5p;hsa-miR-130b-3p;hsa-miR-148b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-20a-5p;hsa-miR-335-3p;hsa-miR-942-5p | 14 | RPS6KA5 | Sponge network | -1.728 | 0.00016 | -1.153 | 4.0E-5 | 0.264 |
56 | AGAP11 |
hsa-let-7d-5p;hsa-miR-107;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-196a-5p;hsa-miR-196b-5p;hsa-miR-20a-3p;hsa-miR-320b;hsa-miR-335-3p;hsa-miR-421;hsa-miR-550a-3p | 11 | CACNB4 | Sponge network | -1.728 | 0.00016 | -2.124 | 0.00021 | 0.26 |
57 | EMX2OS |
hsa-let-7g-3p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-196a-5p;hsa-miR-196b-5p;hsa-miR-20a-5p;hsa-miR-335-3p;hsa-miR-33b-5p | 10 | PDGFRA | Sponge network | -1.088 | 0.10042 | -1.161 | 0.00469 | 0.259 |
58 | PCA3 |
hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-5p;hsa-miR-186-5p;hsa-miR-32-3p;hsa-miR-320b;hsa-miR-3613-5p;hsa-miR-424-5p;hsa-miR-590-3p;hsa-miR-590-5p | 14 | PPM1A | Sponge network | -2.778 | 8.0E-5 | -0.485 | 0.00196 | 0.259 |
59 | PCA3 |
hsa-miR-130b-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-320b;hsa-miR-330-3p;hsa-miR-335-5p;hsa-miR-424-5p;hsa-miR-590-3p;hsa-miR-590-5p | 10 | SOS2 | Sponge network | -2.778 | 8.0E-5 | -0.553 | 0.00084 | 0.258 |
60 | PCA3 |
hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-200c-3p;hsa-miR-330-3p;hsa-miR-590-5p;hsa-miR-93-5p;hsa-miR-96-5p | 11 | PRKACB | Sponge network | -2.778 | 8.0E-5 | -2.003 | 0 | 0.257 |